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 i 
ABSTRACT: 
 
Surgeons play a significant role in the opioid crisis. A standardized, multipronged analgesia 
protocol was implemented with the objective of providing adequate analgesia while reducing 
opioids after outpatient breast and anorectal surgery.  
 
A prospective, pre- and post-intervention study was designed to demonstrate non-inferiority for 
patient-reported post-operative pain. The intervention included patient and provider education, 
and multimodal perioperative analgesic strategies including opioid rescue prescriptions.  
 
We evaluated 266 procedures. After implementation of the STOP Narcotics protocol, average 
post-operative pain scores in the post-intervention groups was non-inferior compared to the pre-
intervention groups [(2.0 vs 2.1/10, p = 0.40, breast procedures) and (2.8 vs 2.6/10, p = 0.33, 
anorectal procedures)]. Opioid prescribing decreased by 50%. Only 45% of patients filled their 
rescue opioid prescriptions.  
 
A standardized pain care bundle significantly decreased opioid prescribing while adequately 
treating post-operative pain. This initiative provides a framework for future guidelines in 
outpatient breast and anorectal surgery.  
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SUMMARY FOR LAY AUDIENCE 
 
Opioid overdoses have become one of the leading causes of preventable deaths in North 
America. Surgeons play a major role for many reasons. First, prescription opioids are still a 
major source of opioid misuse. Second, the risk of chronic opioid use after surgery is 5-15%. 
Finally, diversion of excess, unused prescriptions is a major contributor to opioid misuse.  
 
The impact of implementing a new standardized pain care bundle, termed “The STandardization 
of Outpatient Procedure Narcotics (STOP Narcotics)”, was assessed with the objective of 
adequately controlling patient pain while reducing post-operative opioids after breast and 
anorectal outpatient surgery. 
 
The multi-pronged intervention consisted of 4 main components: Patient Education was 
directed towards clarifying pain expectations, and coupled with written instructions for optimal 
utilization of medications for pain control; Provider Education focused on understanding the 
recommended multi-modal analgesic strategies; Intra-Operative Pain Management Strategy 
included medications targeting pain control and nausea were given by the anesthesiologist; and,  
Post-Operative Pain Management Strategy, where prescription for an anti-inflammatory was 
given, along with instructions for regular acetaminophen use. A separate optional prescription for 
a reduced amount of an opioid was also given.  
Through clarifying patient expectations and providing clear instructions on how to use non-
opioid medications effectively for pain, equivalent post-operative pain control was achieved, 
along with increased patient satisfaction in the post-intervention group. By using multiple non-
opioid medications there was a 50% reduction in opioid prescribing. More significantly, only 
45% of patients filled their opioid prescription. There was no significant difference in 
prescription refills, and appropriate medication disposal of excess medication increased after the 
intervention was implemented.  
If this intervention was implemented province-wide (over 20,000 breast procedures are 
performed in Ontario each year) and opioid prescriptions decreased from 30 pills to 10 pills with 
only 45% of patients filling their prescription, this would result in a decrease of pills consumed 
from 600,000 pills to 90,000 pills for breast surgery patients alone.  Similar standardized 
interventions may be implemented at other institutions and expanded to other more complex 
procedures and surgical disciplines, and may provide a foundation for future guidelines and 
impact the opioid epidemic in a truly meaningful way.  
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1.0 CHAPTER 1: INTRODUCTION AND REVIEW 
 
1.1 OPIOID RESEARCH IN SURGERY 
 
1.1.1 THE RELEVANCE OF OPIOIDS IN SURGERY 
 
It is currently common practice for patients undergoing surgeries to receive an opioid 
prescription for pain control as part of their post-operative care. While effective analgesic agents, 
these psychoactive medications derived from opium or synthetically derived analogues also carry 
the potential for misuse secondary to their euphoric effects.1,2 Common examples used in surgery 
include morphine, codeine, hydromorphone, oxycodone, hydrocodone, fentanyl, and tramadol.2  
With the dramatic rise in opioid medication abuse over the past decade, research in opioid 
prescribing after surgery is a timely and relevant subject. 
 
1.1.2 RESEARCH-BASED STANDARDIZED SCALE 
 
Due to the different potencies among opioids, the number of pills consumed is an inaccurate 
method of measuring and comparing opioid quantities. The accepted research-based method of 
measurement is a standardized scale, comparing different opioid drugs to the equivalent of 1 
milligram of oral morphine (Table 1.1).3 This is referred to as oral morphine equivalents (OME) 
and takes into account the differences in opioid drug type and strength.3 
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Table 1.1 Oral Morphine Equivalents (OME)  
 
Oral Morphine Equivalents 
10 tablets OME 
Morphine 5 mg 50 
Oxycodone 5 mg 75 
Codeine 30 mg   45 
Tramadol 50 mg 50 
Hydromorphone 2 mg 80 
 
Oral Morphine Equivalents for 10 tablets of common surgical prescriptions.  
Agency Medical Directors’ Group.27 http://www.agencymeddirectors.wa.gov/calculator/dosecalculator.htm 
 
 
1.1.3 OPIOID CLASSIFICATION 
 
Opioids may be classified according to their chemistry, receptor, or intrinsic activity.4  
 
a. Natural, semi-synthetic and synthetic opioids 
 
“Natural” opioids, also termed “alkaloid” opioids, are composed of “natural” compounds, with 
familiar examples including codeine and morphine.1,4 When a natural opioid’s structure is 
chemically manipulated, “semi-synthetic” opioids are derived which include heroin, 
hydromorphone, oxycodone and hydrocodone.1,4 Common “synthetic” opioids include tramadol, 
methadone, fentanyl and carfentanil, which are manufactured in a laboratory. These have a 
chemical structure similar to opioids to produce opiate-like effects.1,4 Patterns may be traced over 
the past 30 years that highlight the misuse of each of these opioid classes during distinct time 
periods (See classes of opioids misused, page 3). 
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b. Opioid receptors and intrinsic activity 
 
Opioids are characterized by their complex interactions between three opioids receptors.1,4 
Previously known as mu, delta, and kappa these are now commonly termed MOP (mu opioid), 
DOP (delta opioid), and KOP (kappa opioid).4 Opioids may act at these receptors as agonists, 
antagonists, and partial agonists.1,4 Opioids are effective analgesics, with multiple mechanisms 
and pathways contributing to their analgesic effects. The most relevant of these is their agonistic 
action on MOP receptors in the peripheral and central nervous systems.1,4  
 
1.1.4 OPIOID MISUSE, ABUSE, ADDICTION, TOLERANCE, AND DEPENDENCE  
 
Prescription opioid misuse is defined as using the medication for purposes other than the reason 
prescribed.5 Abuse is defined as consuming the opioid for euphoric effects, rather than for pain.5 
Addiction is the continued seeking out of the drug, despite negative consequences on personal 
life, such as family, work, and friends.5 Tolerance is the escalation of consuming higher doses of 
the opioid, to achieve the same effects in relieving pain or obtaining euphoria.5 Physical 
dependence is established if withdrawal symptoms occur when the opioid is discontinued.5  
 
1.1.5 PATHOPHYSIOLOGY OF OPIOID DEPENDENCE 
 
Consuming opioids leads to an exposure risk for chronic use and subsequently misuse disorders. 
This is particularly true when a more potent or higher dosage of opioid is used, or if the use is 
frequent or for an extended duration.6,7 In addition to analgesia, through neurochemical pathways 
opioids also produce euphoria. This euphoria is central to the risk of prescription drug misuse.6 
With repeated exposure to opioids, higher doses are required to replicate both euphoric and 
analgesic effects, leading to opioid tolerance.5,6 Withdrawal occurs when opioid suppression of 
noradrenaline ceases, resulting in distressing symptoms such as anxiety, agitation, insomnia, 
sweating, muscle cramps and diarrhea.6 Once dependence is established, addiction occurs when 
there is impaired judgement over use and the desire to obtain the medication exceeds other 
priorities resulting in harmful consequences.6,7  
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1.2 EPIDEMIOLOGY OF THE OPIOID CRISIS  
 
1.2.1 EPIDEMIOLOGY OF GLOBAL DRUG ABUSE  
 
Globally, drug abuse has risen to epidemic proportions. In 2016, illegitimate drug use was 
reported in 5.6% of the global population (approximately 275 million people per year).8 In 2015, 
the World Health Organization (WHO) estimated 450,000 deaths as a result of drug use, with 
76% of these deaths attributed to opioid use disorders and overdose.8,9  Initially promoted as one 
of the most powerful analgesic agents, opioids are now one of the leading causes of injury-
related deaths, and cause more harm than any other drugs worldwide.8,9  
 
1.2.2 EPIDEMIOLOGY OF OPIOID ABUSE IN NORTH AMERICA 
 
North America accounts for 85% of global opioid consumption.10 The United States (US) and 
Canada are the first and second largest consumers of prescription opioids per capita in the world, 
respectively.10  
 
The statistics of deaths due to opioid overdoses are alarming. However, for every opioid 
overdose there are many more non-fatal overdoses.8,11 The resultant utilization of emergency 
medical calls and transportation, emergency department visits, hospitalizations and intensive care 
unit stays have had profound economic and emotional effects on patients, families, society and 
health care systems.11–15  
 
a. Epidemiology of opioid abuse in the United States 
 
In the United States, opioid-related morbidity and mortality continues to rise, with the mortality 
rate from opioid overdoses increasing six-fold from 1999 to 2017.11,16 During this time interval, 
there were almost 400,000 Americans deaths, with an average of 130 deaths per day in 2017.11,16 
Deaths from opioid overdoses exceeded deaths attributed to motor vehicle collisions in 2016.15 
The death rate in 2017 was 21.7 per 100,000 (47,700 overdose deaths), with 28,000 of these due 
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to synthetic opioids such as fentanyl.11 The remainder of the overdose deaths are due to 
prescription opioids and heroin.11  
 
b. Epidemiology of opioid abuse in Canada 
 
In Canada, opioid-related morbidity and mortality parallels that of the United States. Deaths due 
to opioid overdoses increased 463% from the year 2000 to 2013.14 In 2016, there were over 
2,800 opioid-related deaths (rate of 7.8 deaths per 100,000), or an average of 8 Canadians per 
day.14,17 Indeed, this was again greater than the average number of Canadians killed daily in 
motor vehicle collisions in 2015.17 Fentanyl-related opioids were responsible for 46% of these 
deaths, with prescription opioids and heroin responsible for the remainder.14  
 
c. Epidemiology of opioid abuse in London, Ontario, Canada 
 
The province of Ontario leads Canada in opioid-related deaths.18 In 2017, there were over 3 
times the number of deaths from opioids overdoses (1,250) compared to motor vehicle collision 
related fatalities (340).19 Despite this, prescriptions for opioids are still widespread, with 14% of 
the population filling an opioid prescription in 2015 (an estimated 1 in 7 people), totalling more 
than 9 million prescriptions.20   
 
It is encouraging that the number of individuals filling opioid prescriptions in Ontario has 
remained stable, with no major increase over the past few years.20 However, more potent opioids 
are being prescribed more frequently.20 Hydromorphone prescriptions, for example, increased by 
29% between 2013 to 2016.20   
 
In Middlesex-London, Ontario, Canada where this integrated thesis work completed, mortality 
related to opioid overdoses was twice as high as the rest of the Ontario in 2012.21 Opioid-related 
emergency department visits, hospitalization rates, and admission to substance misuse programs 
consistently exceeded Ontario’s average rates.21  
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1.2.3 CLASSES OF OPIOIDS THAT ARE MISUSED  
 
Since the 1990s, different opiate classes have been implicated in opioid overdoses during three 
separate time intervals. An increase in overdoses from 1999-2010 was likely due to a rapid 
increase in physicians prescribing opioids in the 1990s, and overdose deaths involved natural 
(e.g. morphine, codeine) and semi-synthetic (e.g. hydromorphone, oxycodone, hydrocodone) 
opioids.11,22,23 The second rise was a sudden increase in overdose deaths in 2010 due to 
community dissemination of heroin.11,22 Then in 2013, there was a significant increase in deaths 
due to synthetic opioids (such as fentanyl and carfentanil), particularly illicitly manufactured 
fentanyl.11,15,22 Prescription opioids, heroin and synthetic illicit opioids all still play major roles 
in opioid morbidity and mortality today.  
 
Figure 1.1 
 
 
 
Figure 1.1 Overdose Deaths by Type, United States, 2007-2017; National Vital Statistics System, 
Centers for Disease Control (CDC), available at: 
https://www.cdc.gov/drugoverdose/data/analysis.html 24 
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1.2.4 PRESCRIPTION TRENDS OF OPIOIDS IN NORTH AMERICA 
 
While the number of opioid prescriptions remains high, the overall opioid prescribing rate has 
plateaued and is decreasing in some locations. This suggests that health care providers may have 
become more cognitive about the risks of opioid prescriptions and are more cautious in their 
prescribing practices.   
 
In the United States the opioid prescribing rate has declined 19% from 2006 to 2017.11 Despite 
this, the amount of opioids prescribed per person still remains 3 times higher than previously 
reported in 1999.11 In 2017 there were still more than 17% of Americans that filled at least one 
opioid prescription that year.11  
 
In Canada, though the overall quantity of opioid (oral morphine equivalents) in each prescription 
decreased by 5%, the number of opioid prescriptions continued to rise by 7% between 2012 and 
2016.25 Opioid prescriptions were used by 13% of the population in 2017, a decrease from 15% 
in 2013.14 This may reflect smaller but more frequent prescriptions to fewer individuals. Of this 
13%, approximately 2% of the population reported using the prescription for non-medical 
purposes.14 The number of fentanyl prescriptions decreased by 7%, but the proportion of 
prescriptions for stronger opioids (for example, hydromorphone) increased by 10% from 2012 
and 2016.25  
 
1.2.5 HISTORY OF THE PHARMACEUTICAL OPIOID CRISIS 
 
While illegal sources and production of opiates has increased, a large rise in morbidity and 
mortality has actually been associated with increased use of legitimately obtained pharmaceutical 
prescription opioids.8,9,22,23  
 
This initial rise began in the 1990s when pain specialists and advocacy organizations began 
promoting pain as the “fifth vital sign”, and that our nation was facing an epidemic of untreated 
pain.7,22,23 Industry-sponsored pain management training events and conferences, sophisticated 
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marketing strategies and the promotion of opioid use for non-cancer pain all influenced 
physician prescribing practices.23 
 
During this time period, the number of opioid prescriptions increased dramatically. Written 
opioid prescriptions increased by 300% in the United States between 1991 and 2009.13 In 
Canada, written oxycodone prescriptions increased by 850% between 1991 and 2007.26  
 
While there was comparable efficacy to other opioids, with the aggressive marketing of 
oxycontin, global sales rose from US $48 million in 1996 to $2.4 billion in 2012.7,22,23 This 
increase was paralleled to a lesser extent for other opioids, which also experienced an 
unprecedented rise.7,22,23 
 
Opioid misuse, addiction and overdose deaths have paralleled the volume of opioids 
prescribed.13 This public health crisis has now been recognized and while primary, secondary 
and tertiary prevention are all areas of focus there is no simple solution. North America is 
currently dealing with the aftermath of this epidemic, the impact of which will affect individuals, 
families, society, and health care for decades to come.  
 
1.3 THE ROLE OF THE SURGEON AND CARE TEAM 
 
With the recent spike in opioid overdoses secondary to illicit fentanyl, and also the attention 
surrounding heroin misuse, it may seem that surgeons play a minimal role in the opioid crisis, as 
those medications are not routinely prescribed. In addition, much responsibility has been 
attributed to opioids prescribed for chronic non-cancer pain (not commonly managed by 
surgeons), leading to chronic use and eventual misuse.  
 
The surgeon should assume an important role in the opioid crisis for multiple reasons.  First, 
prescription opioids obtained from physicians, including surgeons still have a major role in 
opioid morbidity and mortality. Second, with every post-operative opioid prescription there is 
risk of chronic use and future opioid misuse disorder. Third, prescriptions after surgery are often 
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excessive and variable, with only a fraction of the medication prescribed being consumed. 
Finally, appropriate disposal of excess medication is generally quite poor.  
 
1.3.1 MISUSE OF PRESCRIPTION OPIOIDS 
 
Misuse use of opioids is defined as consumption for purposes other than the reason prescribed. 
This includes use by individuals who obtained prescription opioids from other sources.14 
 
Data from the National Survey on Drug Use and Health indicates that prescription opioid pain 
relievers for non-medical use are most commonly obtained from a friend or relative in the 
majority (53.0%) of cases.27 Other sources included were from a single physician, “double 
doctoring” or prescriptions from multiple physicians, prescription fraud or forgery, theft, street 
drug dealers and internet purchases (Figure 1.2).14,27–29 
 
Figure 1.2 
 
 
 
Figure 1.2 Sources of misused prescription opioids among people aged 12 or older in 2016.27 
Available at: https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-
FFR1-2016.pdf 
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The range of past year prescription opioid misuse prevalence in individuals aged 11-30 years was 
0.7%-16.3%.30 The majority of non-medical users are men (56%), between the ages of 18-34 
years (54%), of a white race (73.5%), with a low family income (less than US$50,000).28  
 
Fentanyl is unique in that it can be obtained both through the pharmaceutical industry, or illicitly 
manufactured. Therefore, it is difficult to ascertain the amount that is obtained legitimately 
through physicians and misused as a “prescription opioid”. 
 
Despite a plateau and decline of prescribing rates per person, prescription opioids remain a major 
cause of opioid morbidity and mortality in North America. The CDC reported prescription 
opioids accounted for 218,000 of the 400,000 deaths from opioid overdoses between 1999 and 
2017.11,16   
 
Currently, prescription opioids are involved in more than 35% of all overdose deaths in the 
United States alone.11,14 In addition, the majority of illicit fentanyl and nearly 75% of recent 
heroin users report being introduced to opioids through prescription medications.31   
 
1.3.2 RISK OF CHRONIC OPIOID USE AFTER SURGERY 
 
A prescription opioid may be a common avenue to opioid misuse disorders.31 Indeed, up to 75% 
of heroin users report being initially prescribed an opioid by a physician.31  Surgery may also be 
a risk factor for chronic opioid use.  In a survey of chronic pain patients, one-third reported 
receiving their initial opioid prescription from a surgeon.32  
 
In a study of 536,767 opioid naïve patients who filled an opioid prescription, 5% became long 
term users.33 Brummet retrospectively analyzed 36,177 surgical patients undergoing both major 
and minor surgery.34 Major procedures included ventral incisional hernia repair, colectomy, 
reflux surgery, bariatric surgery, and hysterectomy. Minor procedures included varicose vein 
removal, laparoscopic cholecystectomy, laparoscopic appendectomy, hemorrhoidectomy, 
thyroidectomy, transurethral resection of the prostate, parathyroidectomy and carpal tunnel 
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release. New persistent opioid use between 90 and 180 days was increased to a similar extent in 
both groups (major surgery 6.5% vs minor surgery 5.9%).34 
 
When defining chronic opioid use as a prescription for an opioid between 60 days to 1 year after 
surgery, Alam demonstrated that patients were 44% more likely to develop chronic use 
compared to those who did not receive an opioid.35 When examining 39,140 of opioid naïve 
patients 66 years of age or older, Clarke demonstrated 3.1% of patients continued to receive 
opioids for more than 90 days after surgery.36 Sun described a lower incidence of 0.119%-1.41% 
prolonged opioid use after surgery in opioid naïve patients.37 This study may underestimate 
incidence as it defined chronic opioid use as more than 10 opioid prescriptions filled, or more 
than 120 days supplied between 3 and 12 months after surgery.37  
 
In opioid naïve women after breast surgery 10% continued to fill prescriptions beyond 3 months 
after surgery.38 Anxiety and depression were identified as risk factors for using higher amounts 
of OME over prolonged periods of time, compared to those women without these variables  
(13.4% vs 9.1%).38  
 
Opioid-naïve cancer patients are at increased risk for chronic opioid use defined as opioid 
prescriptions 90-180 days after surgery. Lee evaluated 68,463 patients, and among opioid-naïve 
patients risk of persistent opioid use was 10.4%.3940 This is particularly relevant, considering the 
recent trend to favourable prognosis and long-term survivorship of breast and colon cancers.   
 
These studies re-emphasize the role of the surgeon through characterizing the opioid-exposure. 
With an increasing number of ambulatory surgeries in North America, a 5-15% risk of chronic 
use comprises a substantial concern.41,42 While surgery is a risk factor for chronic use, the 
percentage of patients with chronic use that transition to misuse is unknown. However, once a 
patient transitions to chronic opioid use cessation is rare, and it is reasonable to postulate these 
patients may be at higher risk of eventual misuse.43,38 Therefore, if opioids are prescribed it 
emphasizes the need to intervene and taper in the immediate post-operative period.43,38  
 
 12 
a. Risk factors for chronic opioid use 
 
Surprisingly, intensity of pain after surgery may be unrelated to the risk of chronic opioid use. 
Indeed, in the study by Goesling including patients undergoing total hip and knee arthroplasty, 
the pain intensity in the 4-8% of patients with chronic use at 6 months was unrelated.34,44 
Brummett et al compared 29,068 patients receiving minor surgical procedures to 7,109 major 
procedures.34 The rate of chronic opioid use was similar between the 2 groups ranging from 
5.9% to 6.5%.34 
 
Risk factors for new persistent opioid use include tobacco use, alcohol and substance use 
disorders, younger age, lower household income and comorbid conditions, regardless of surgical 
procedure completed.34 Other preoperative pain disorders (back pain, arthritis, and centralized 
pain conditions – specifically fibromyalgia), anxiety and depression have all been independently 
associated with persistent opioid use.34,36,45 In patients who are undergoing curative-intent cancer 
surgery, chemotherapy was associated with a higher risk of chronic opioid use.39 Chemotherapy 
and risk for peripheral neuropathy may account for this association. Specifically risk factors 
identified in outpatient procedures included age, depression, psychotropic medications, pain 
impairment and previous substance abuse.46  
 
1.3.3 VARIABLE AND EXCESSIVE OPIOID PRESCRIPTIONS 
 
Approximately 50 million outpatient procedures were performed in the United States in 
2010.41,42 In Canada, the Canadian Institute for Health information (CIHI) reported 1.8 million 
outpatient procedures in 2005.47 The rates of outpatient surgical procedures increased by 300% 
in the 10-year period from 1996-2006 in the United States, and continues to increase in North 
America on an annual basis.41,42 Considering a significant portion of these patients receive an 
opioid prescription after outpatient surgery, this truly is an astounding amount of medication.  
 
There is a lack of evidence-based guidelines that specifically address the appropriate quantity of 
opioid to prescribe after outpatient surgical procedures. Available clinical standards are 
available, however, are quite general and directed towards inpatient procedures, patient-
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controlled analgesia, and regional or multimodal techniques.48 Current surgical training 
curriculum provides inadequate training on appropriate post-operative analgesia for medical 
students and residents, leading to significant regional variation in prescribing practices.  
 
The lack of guidelines has also contributed to excess opioid prescribing after surgery. Recently, 
studies have demonstrated that patients often consume only a fraction of the opioids 
prescribed.49,50,51  
 
Hill reported excessive and variable prescriptions among opioid-naïve patients.49 The median 
number of pills and range prescribed were as follows: partial mastectomy (PM) 20 (0-50); PM 
with sentinel lymph node biopsy (SLNB) 20 (0-60); laparoscopic cholecystectomy (LC) 30 (0-
100); open inguinal hernia (IH) 30 (15-120).49 Overall, only 28% of the pills were actually 
consumed (PM 15%, PM SLNB 25%, LC 33%, and IH 30%), with less than 2% of patients 
obtaining refills.49 In a variety of major inpatient surgical procedures, they reported patients 
consuming 38% of prescribed opioid pills, with 15 opioid pills satisfying the opioid needs of 
88% of patients discharged on post-operative day one.52  
 
Tan prospectively documented that opioid-naïve patients undergoing open and laparoscopic 
abdominal procedures were prescribed a median of 150 OME (equivalent to 20 oxycodone pills), 
but at their first post-operative visit had only consumed 30 OME or 4 pills.53 Only 4.5% of 
patients required additional prescriptions and 77% of patients were satisfied with their pain 
management.53 Fuji re-affirmed a wide range in the amount of opioid prescribed, of which only 
27% was consumed after general and orthopedic surgical procedures.54  
 
Subsequent studies have reproduced similar results and are summarized in two recent systematic 
reviews.51,50 Overall, the low quantity of opioid consumed may be underestimated considering 
they do not usually include if the patient received instructions for non-opioid multimodal 
analgesia, which may have further reduced opioids consumption.  
 
While patients may only consume a fraction of the opioid prescribed, consumption does correlate 
and increase with higher opioid prescriptions. Howard demonstrated that for every additional pill 
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prescribed, the patient will consume an additional one-half of a pill, likely due to an affect 
heuristic.55  
 
These excessive prescriptions lead to unused medication which is one of the root problems in the 
non-medical use of prescription opioids. Considering data from the National Survey on Drug Use 
and Health indicates that prescription opioid pain relievers for non-medical use are most 
commonly obtained from a friend or relative in the majority of cases, this indeed poses a 
significant problem.27  
 
1.3.4 APPROPRIATE DISPOSAL OF OPIOIDS 
 
With the described findings of excess medication, a potential solution is appropriate disposal of 
this medication. Unfortunately, appropriate disposal at a pharmacy – even with specific 
instructions - is low (5-20%).  
 
Appropriate disposal methods described have included return to pharmacy, drug take-back 
programs, disposal in the trash after combining with an unpalatable substance or flushing down 
the toilet when options are not accessible.56 Medication disposal in the trash or flushing down the 
toilet has been discouraged due to environmental concerns.  
 
Reports of appropriate disposal without instructions are approximately 5-10%. Even with giving 
direct written disposal instructions, Fujii reported only 18% compliance of patients. This results 
in a tremendous amount of leftover medication in homes and communities, available for 
diversion.54,57,58,59,60 This is especially significant in the youth population, who often have 
unrestricted access to where the medication is stored.27,61,62 
 
Various interventions have been recommended to improve disposal. Education has remained a 
foundation of many studies.58,63,64 Hasak and Rose prospectively demonstrated an increase in 
appropriate disposal from 11% to 22% and 5% to 27% in surgical patients who received an 
educational brochure on appropriate disposal.63  
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Drug take-back programs, a national prescription drug take-back day, drug kiosks, and mail-in 
programs have been implemented in some locations often with news releases citing success and 
tons of medication returned.65,66 However, when considering the overall quantity of opioid 
medication prescribed compared to what is returned, the effectiveness of drug take-back 
programs is likely small.67,68,69 
 
Although there is a lack of knowledge regarding appropriate drug disposal, even with education 
it remains quite low. Currently, there is little incentive to return unused pills. Other reasons for 
poor disposal are inherent cost of medication to the consumer, perceived potential for future need 
and lack of convenient disposal.  
 
1.4 THE IMPORTANCE OF ANALGESIA IN OUTPATIENT SURGERY 
 
In outpatient surgery, an adequate analgesia and symptom protocol is extremely relevant as 
uncontrolled pain, nausea or other symptoms result in longer discharge times and potential 
hospital stays.71 Moderate to severe pain will prolong recovery room stay by 40-80 minutes.7172 
Optimal analgesia not only facilitates discharge, but decreases re-admission rates, improves 
patient satisfaction and facilitates earlier return to function.72 Over recent years, outpatient 
surgery has become increasingly common, and may involve more extensive and painful 
operations. The role of effective, opioid-sparing, multimodal analgesia thus becomes more 
critical role in facilitating the discharge and recovery process of these patients.  
 
1.5 INTERVENTIONS FOR OPIOID REDUCTION AND EFFECTIVE 
ANALGESIA IN SURGERY 
 
Evidence-based opioid-reduction strategies after surgery that have been explored include: (1) 
patient education (2) provider Education (3) opioid-reduced prescriptions (4) non-opioid 
multimodal analgesia strategies.70 
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1.5.1 PATIENT EDUCATION 
 
Unfortunately, current analgesic practice is often providing an opioid prescription after surgery 
with instructions to use as needed for pain. This does not commonly include education about 
other medical or conservative adjuncts or education about expected levels of discomfort after 
surgery.  This practice results in the following: a) the patient fills the prescription nearly 100% of 
the time; b) the patient may take the entire prescription for only mild discomfort; c) the patient 
may not tolerate or use the opioid, leaving excess within the home;49,50 and d) the patient is left 
questioning other analgesic options without instructions on their optimal use;74 
 
In 114 women, Katz demonstrated how pre-operative anxiety was an important variable 
contributing to the prediction of acute pain after surgery.75Another systematic review evaluating 
the effectiveness of physician-patient communication and health outcomes, highlighted a 
positive correlation between effective communication and improved patient health outcomes 
including analgesia, symptom resolution, function and emotional health.76,77,78  
 
Sugai prospectively evaluated a control group in outpatient surgery who received no patient 
education, to an intervention group that received both oral and written forms of patient 
education.73 This education surrounded patient expectations, natural endorphins, the negative 
effects of narcotics, and mechanisms of non-opioid analgesics.73 Despite 100% of the control 
group filling a narcotic prescription vs 10% of the intervention group, average pain scores were 
significantly lower in the intervention group.73 Perioperative education has been reaffirmed to 
have a positive correlation with patient satisfaction of analgesia, pain scores, and opioid-
reduction.76-77,79–81 Written instructions have been compared to verbal instructions in patients 
being discharged from hospital. Studies have revealed that a combination of written and verbal 
information, particularly on pain relief, are valued by patients. Caregivers also have an integral 
role in receiving instructions prior to discharge.82 In a Cochrane review, parents had a better 
understanding of the care needed for pediatric patients when given both written and verbal 
instructions compared to written instructions alone.83  
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1.5.2 PROVIDER EDUCATION 
 
It is general practice for every patient to receive an opioid prescription after surgery. Surgery is 
inherently painful and with recent emphasis of pain labeled “the fifth vital sign” and the 
underestimation of the addiction potential of opioids, excessive opioid prescriptions are often 
given with the intention of better pain control.  
 
There is now evidence that patients use a fraction of the opioids prescribed and that non-opioid 
multimodal analgesic medications are often equally effective in controlling post-operative 
pain.50,51,122 This calls for a culture shift, which must start with the surgeons and involve the 
entire care team.  
 
When Hill discussed findings of the wide variation and excess opioid prescriptions along with 
actual opioid consumption, opioid prescribing dropped dramatically.84 The total number of pills 
that would have been prescribed decreased by 53%.84  
 
Described methods of education include divisional or perioperative rounds, patient quality and 
safety meetings, emails, educational assist devices (cards) or meeting with each department 
separately.70 Stanek educated providers through educational assist devices (pink cards) which 
served as a memory prompt and were given to physicians, nurse practitioners and medical 
trainees.85 Howard disseminated practice guidelines to staff though video and oral presentations 
and reduced opioid prescribing by 38%.55 Hill distributed education through emails, surgery 
section meetings, resident forums, and grand rounds.84   
 
1.5.3 OPIOID-REDUCED PRESCRIPTIONS 
 
Prescriptions for opioids may be reduced through the following methods. First, surgeons may be 
educated on the need for opioid reduction and may use their own judgement to reduce opioid 
prescriptions. Second, written guidelines on recommended quantity of opioids to prescribe for 
procedures may be distributed across surgical divisions.84 Third, electronic medical records 
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(EMRs) may be adjusted to have lower automatic quantities and duration of opioid prescriptions. 
Finally, rescue-opioid prescriptions may be utilized.  
 
a. Institutional guidelines 
 
Guidelines created by the Department of Surgery, Michigan Medicine were made available to the 
different surgical departments based on a previous pre- and post-intervention study comparing 
opioids prescribed to opioids consumed after surgery. Five months after guideline 
implementation, the median amount of opioid prescribed was reduced from 250 OME to 75 
OME with no change in prescription refills (2.5%). Median post-operative opioid use had 
decreased from 30 OME to 20 OME.  There is always crossover between written guidelines and 
provider education, however, together they may have a synergistic effect.52,84  
 
b.  Electronic health systems 
 
Simply decreasing the default quantity and duration of opioid tablets in an EMR system is 
another method to decrease opioid prescriptions.85,88,89 Luk changed the default opioid 
prescription from one that automatically offered weight based acetaminophen + codeine or 
hydrocodone, to an order set with acetaminophen and ibuprofen.90 Opioid prescribing decreased 
from 82% to 15%.90  
 
 1.5.4 NON-OPIOID MULTIMODAL ANALGESIC STRATEGIES  
 
It is current general practice to provide most perioperative analgesia through opioid analgesics. 
While effective analgesic agents, their use must be balanced with well documented side effects 
including post-operative nausea and vomiting, sedation and falls, ventilatory depression, 
constipation, ileus, urinary retention and pruritus.91  
 
Adequacy of pain control is imperative in determining if a patient can be discharged safely from 
an ambulatory facility.92 It requires an effective perioperative analgesic technique that is 
intrinsically safe, has minimal side effects and may be easily managed in the home setting.92 
 19 
Perioperative multimodal analgesia has been proposed as a safe, inexpensive method to improve 
pain control and nausea, reduce opioid use, and contribute to a low-risk, opioid-sparing clinical 
practice.93 
 
1.5.5 PRE-EMPTIVE AND PRE-OPERATIVE MULTIMODAL ANALGESIA 
 
Recent guidelines in ambulatory surgery have advocated for a multimodal, opioid-sparing 
analgesic approach in the immediate perioperative period.94–96 The concept of pre-emptive 
analgesia is altering central processing, to decrease the incidence of hyperalgesia after surgery.97 
The clinical evidence for the timing of administration of pre-emptive medications is debatable as 
to whether there is more effect if they are given pre- or intra-operatively.98 
 
a. Local Anesthetic Nerve Blocks.  
 
The infiltration of local anesthetic agents, such as lidocaine, in or around the border of a surgical 
wound have consistently been shown to reduce post-operative pain, and may decrease post-
operative opioid use.99,100–102,103 When administered during or before surgery, this decreases both 
analgesic and anesthetic requirements.72 For example, an ilioinguinal nerve block, or 
iliohypogastric nerve block significantly decreased opioid analgesic requirements in patients 
undergoing inguinal hernia repair by providing 6-8 hours of post-operative analgesia.104 There 
has been recent interest in liposomal bupivacaine, to produce prolonged analgesia with single 
dose infiltration into the surgical site.  In a pooled analysis of 9 studies representing 5 surgical 
procedures, liposomal bupivacaine was associated with lower pain scores and less consumption 
of opioids post-operatively.105,106 This medication is not yet licensed in Canada.  
 
b. Regional Anesthetic Nerve Blocks.  
 
There is an extensive body of literature examining the effectiveness of regional anesthetic 
techniques to improve analgesia.107 These include upper and lower extremity blocks, central 
neuroaxial, paravertebral blocks and other regional nerve blocks. The majority have evidence for 
efficacy in post-operative analgesia, however, are also associated with time, cost and 
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complications such as hematoma formation.108-112 Coupled with the variability due to 
administrator experience, these factors have led to mixed views on their utility in various 
outpatient surgery.108–112 Certainly, while central neuroaxial (epidural and spinal) blocks  provide 
excellent analgesia, these are not practical techniques in outpatient surgery.72 
 
c. NSAIDs 
 
Pre-emptive use of NSAIDs has been associated with improved analgesia and lower opioid 
consumption post-operatively. The timing of NSAID administration has been debated and 
studies have shown effectiveness when given both pre- and intra-operatively.98,113 
 
In patients undergoing laparoscopic cholecystectomy, ketorolac has been shown to decrease 
opioid requirements and improve ventilatory parameters post-operatively.114 A meta-analysis of 
13 randomized clinical trials evaluated a single peri-operative dose of ketorolac, establishing it as 
an effective adjunct in multimodal regimens to reduce post-op pain.115 It is also therapeutic in 
reducing post-operative nausea and vomiting.115 While many guidelines advocated for pre-
emptive use of NSAIDs, there are challenges to standardizing this practice due to the variability 
of the anesthetist and suitability of the individual patient.  
 
d. Dexamethasone 
 
A single perioperative dose of dexamethasone has been shown to be effective in decreasing post-
operative pain in a meta-analysis of 45 randomized clinical trials.116,117 Opioid consumption has 
also been noted to decrease with dexamethasone.116,117,118 Typical peri-operative doses are 
between 0.1 – 0.2 mg/kg.117 Dexamethasone also decreases nausea and vomiting, is an appetite 
stimulant and may promote a sense of well-being.117–120 These positive attributes facilitate the 
discharge of outpatient procedures.116,117,119,120 There is no evidence of delayed wound healing or 
increased wound infections with a single perioperative dose of dexamethasone.116,117  
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1.5.6 POST-OPERATIVE OPIOID-SPARING MULTIMODAL ANALGESIA 
 
After outpatient surgery, opioids may be used as rescue therapy, or regularly for a short duration 
of less than 3 days with immediate tapering and discontinuation.96 Rescue therapy is defined as 
an optional opioid prescription, that may be filled if non-opioid analgesia options do not 
satisfactorily control the patient’s pain. Two recent systematic reviews reaffirmed that opioids 
consumed in surgery are a fraction of what is prescribed, with patients rarely consuming more 
than 15 pills.51,50 This is likely an over-estimation of the number of opioid pills needed, as many 
studies did not include instructions for other analgesic options, which may in fact have decreased 
overall opioid requirements.  
 
a. NSAIDs 
 
Benefits of NSAIDs include analgesic, anti-inflammatory and antipyretic effects. NSAIDS may 
be equivalent to opioids in controlling acute post-operative pain.121,122 Three clinical trials 
involving 1202 patients with moderate or severe pain after surgery found that fewer patients 
needed rescue therapy with ibuprofen alone, than with oxycodone alone.122 In another double-
blinded randomized control trial (RCT) in 104 patients, there was equivalent post-operative pain 
in those given 800 mg of ibuprofen vs 800 mg of acetaminophen with 60 mg of codeine as post-
operative prescriptions.121 Stessel compared controlled-release oxycodone vs. naproxen in a RCT 
involving 105 patients and also found no significant difference in patient-reported pain levels.123  
 
NSAIDs are safe and effective analgesic agents, especially when used in short duration in an 
elective non-comorbid population. Caution must be used, however, as they have well 
documented side effects including gastrointestinal ulceration, renal tubular damage and platelet 
dysfunction.124 There are also concerns of their use in those with severe cardiovascular disease 
and those patients with high risk of bleeding, although most reviews support that the increase of 
bleeding is equivocal at best.124,125   
 
Meloxicam is one of the only NSAIDs that requires a prescription in Ontario. This is likely due 
to the risk of cardiovascular thrombotic events, although recent studies suggest it does not 
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interfere with platelet aggregation.126 It reversibly inhibits cyclooxygenase-2 which results in 
decreased formation of prostaglandin precursors and has antipyretic, analgesic, and anti-
inflammatory properties.127 A meta-analysis reporting on 12 RCTs suggested that when 
compared to a non-COX-2 selective NSAIDs, meloxicam resulted in fewer peptic ulcer bleeds, 
less dyspepsia and less frequent discontinuation related to adverse GI related events.128  
 
b. Acetaminophen 
 
Acetaminophen or paracetamol is a safe, well-tolerated medication that is an effective opioid-
sparing analgesic agent for mild to moderate pain.129-131 A maximum daily dose of four grams 
per day is recommended, however, a special consideration is cirrhotic patients where it should be 
used in reduced doses (maximum daily dose of two grams).130 Acetaminophen is recommended 
routinely in the post-operative period for both its analgesic and antipyretic properties. 
 
In acute post-operative pain, a Cochrane review of 51 studies with 5,762 patients found that a 
single dose of acetaminophen reduced patient-reported pain and was associated with few adverse 
events.130 Current evidence suggests that acetaminophen in combination with an NSAID work 
synergistically to offer superior analgesia than with either drug alone.129,132  
 
c. NMDA antagonists, Alpha-2 agonists, Gabapentinoids, Selective 
Serotonin Reuptake Inhibitors and Tricyclic Antidepressants 
 
Ketamine, amantadine and dextromethorphan are NMDA receptor antagonists that have been 
used in the setting of palliative care, chronic and neuropathic pain, and may be an adjunct in the 
treatment of post-surgical pain.72,133  There is mixed evidence regarding their benefit as ketamine 
had previously fallen out of favour due to its side effect profile.72 A recent review, however, of 5 
meta-analyses and 39 clinical trials founds that ketamine does reduce opioid consumption 
although its utility in lowering pain scores is less clear.134-136 Its use may be more amenable for 
patients with a history of chronic opioid use, in which ketamine or amantadine are an adjunct for 
decreasing opioid consumption and may contribute to post-operative analgesia.135 Due to its 
intravenous form and often being given as a slow infusion post-operatively, ketamine has more 
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of a role in major surgical procedures than outpatient procedures.72, 134 While ketamine is 
generally considered a safe drug, there are concerns for possible neurotoxicity and effects on 
memory.136 The use of smaller doses has resulted in less frequent adverse events and greater 
physician acceptance.72 
 
Dexmedetomidine, clonidine and tizanidine are alpha-2 agonists which possess anxiolytic and 
sedative properties due to their central antinociceptive activity.72,137  A Cochrane Review in 2016 
examining dexmedetomidine in 422 patients from 7 RCTs after abdominal surgery showed no 
reduction in pain scores, but decreased breakthrough opioid consumption in the first 24 
hours.133,137 In a meta-analysis of clonidine in 2012 of 19 RCTs, there was an opioid-sparing 
effect within 24 hours, although less pronounced than dexmedetomidine.133,138  Since this time, 
other studies have reproduced similar results.139 Tizanidine, differs in its shorter duration of 
action, with less systemic effects and may result in less post-operative pain after surgery, 
although there is much less published data.140  
 
Methocarbamol, cyclobenzaprine, clonidine and tizanidine all have muscle relaxing properties.133 
This muscle-relaxing effect may be responsible for some opioid reduction. More evidence is 
needed, particularly with methocarbamol and cyclobenzaprine as to the role of muscle relaxants 
as analgesic adjuncts, before they can be routinely recommended post-operatively.133,138,140 
 
Gabapentinoids (gabapentin and pregabalin), were initially developed as anticonvulsant 
medications.133 Now used more commonly for chronic neuropathic pain, their uses have been 
expanded to post-surgical pain, suggesting effects of opioid-reduction and the prevention of 
chronic pain syndromes.72,133,141,142 Most meta-analyses concur their use results in a decrease in 
opioid consumption, although there are various reports on their actual reduction of post-operative 
pain scores.143,144 Higher-quality studies using better grading of articles included and meta-
regression suggest the extent of opioid-reduction is likely overestimated.145,146  In his meta-
analysis with trial sequential analysis, Doleman  reported that in 13 trials (with low risk of bias) 
of 132 trials comparing gabapentin vs. placebo there was a reduction of 24 hour opioid 
consumption equivalent to 3.1 mg of morphine.146 Given the predefined minimal clinically 
significant effect of morphine is 5 mg in 24 hours, their conclusion was there is an absence of 
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any clinically relevant beneficial effect of gabapentin and harm may be pending.146 The dosing 
of pregabalin is more predictable and the majority of meta-analyses also conclude a decrease in 
opioid consumption.147-149 In 2015 a meta-analyses by Eipe included 43 studies using pregabalin 
for acute pain which demonstrated a 16% reduction in analgesic consumption along with a 
questionable small reduction in pain scores.147 Sedation, dizziness and blurred vision were 
relatively common.147 In a meta-analysis involving 55 studies in 2015 by Mishriky, pregabalin 
also reduced opioid consumption at 24 hours in addition to pain scores, however, side effects 
were common. Data was insufficient to reach any conclusions regarding persistent pain.148 Firm 
evidence for the routine use of routine gabapentin and pregabalin is still lacking, especially 
considering the current minimal benefit in pain control and the well-documented side effects.146  
 
Commonly used in depression and anxiety there has been recent interest in serotonin 
norepinephrine reuptake inhibitors (eg. Duloxetine) as analgesic adjuncts.107  Although limited 
evidence suggests there may be an opioid sparing effect, it does not consistently reduce post-
operative pain scores when compared to placebo.107 The opioid-sparing effects reported are 
modest, and more evidence is needed to determine the role of SNRI’s in the treatment of acute 
postoperative pain.150-152   
 
Tricyclic antidepressants (amitriptyline and desipramine) are commonly used to treat chronic 
pain conditions, and their role has been questioned in the management of acute post-operative 
pain.153 This evidence is sparse with Kerrick and Vahedi reporting amitriptyline as an adjunct to 
opioids was no more effective than placebo in controlling pain.153-158 Considering other evidence 
remains ambiguous with minimal if any effect, while TCAs have an integral role in the 
management of chronic pain conditions, their routine use in acute post-operative pain is currently 
not recommended.  
 
 
1.5.7 NON-PHARMACOLOGIC TECHNIQUES  
 
Other nonpharmacologic techniques discussed in the literature are transcutaneous electrical nerve 
stimulation, acupuncture, cryoanalgesia, ultrasound, laser stimulation and hypnotherapy. Well-
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designed clinical trials are needed prior to the recommendation of these strategies to establish the 
benefits on post-operative pain.72  
 
Cryoanalgesia or ice therapy has been advocated for soft tissue injuries since the time of 
Hippocrates. An RCT by Koc analyzed ice therapy at 2, 6, and 24 hrs after the operation. There 
were significant differences in the visual analogue pain scale ratings between the groups and they 
concluded it was a safe, effective technique for providing analgesia following inguinal hernia 
repair.159 Another RCT published in the Journal of the American College of Surgeons assessed 
ice therapy in patients who had midline laparotomies and concluded that both opioid use and 
pain were lower in the cryotherapy group.160 There is some concern that ice therapy may cause 
skin flap necrosis, however these are infrequent case reports. While there is minimal evidence for 
ice therapy in breast surgery, it is reasonable to extrapolate data from other surgical procedures 
and hypothesize it may be effective in reducing both pain and opioid use. 
 
1.5.8 CHRONIC POST-SURGICAL PAIN  
 
As one predictor of chronic pain syndromes after surgery is acute pain, effective analgesia in the 
post-operative period is consequential. Other predictors include age, sex, genetics and pre-
operative pain.156 Biologic, environmental mechanisms and psychosocial mechanisms all play a 
role in the development of chronic pain.157 Current peri-operative pharmacologic interventions 
which may have evidence for suppressing and preventing sensitization and development of 
chronic pain include NSAIDs, ketamine, local anesthetics and the use of multimodal 
analgesia.157,158 The use of gabapentin, pregabalin, TCAs and SNRIs to prevent chronic pain 
syndromes after surgery is sparse and weak, and needs to be further evaluated.157,158   
 
 
1.6 “BUNDLES” IN SURGERY 
 
The concept of “bundles” has been introduced in surgery through combining multiple evidence-
based strategies to obtain a greater overall and often synergistic effect. Enhanced recovery after 
surgery (ERAS) is an example and centers on a multidisciplinary team approach in developing 
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evidence-based, patient centered pathways to optimize the patients’ function and recovery.161 
This is often an integrated continuum, from the pre-hospital stay until discharge and has 
revolutionized the recovery process after surgery by reducing post-operative care time by more 
than 30% and reducing complications by up to 50%.162 These “bundles” have been focused 
primarily on inpatient procedures, however, may also be effective in the outpatient setting.162-165  
Minimizing opioids is one of the many multi-pronged strategies of ERAS protocol, but there is a 
lack of current guidelines and recommendations as to the quantity and duration of post-operative 
opioids to prescribe, as well as the integration of multimodal analgesia in the outpatient setting.  
 
1.7 OBJECTIVES AND PURPOSE OF THE THESIS 
 
1.7.1 DEFINING THE PROBLEM IN BREAST AND ANORECTAL SURGERY 
 
The scope of the opioid crisis in North America has been outlined above. The evidence of the 
potential roles of the surgeon in the opioid prescription problem has also been explored.  
 
There is a lack of current guidelines and recommendations as to the quantity and duration of 
post-operative opioids to prescribe in outpatient anorectal and breast surgery. These procedures 
were chosen as they are almost uniformly performed as outpatient procedures. This surgical 
cohort represented a population suitable to expand recently studied standardized opioid-reduction 
protocols which were successful in other outpatient procedures at LHSC(Appendix 5.5).57 In 
addition, while opioid-reducing interventions have been studied there are few examining the 
feasibility of combining these interventions together in a bundle in these patients. Furthermore, 
the majority of literature on opioid reduction often includes prescription refills as an indirect 
marker for adequate control of pain rather than patient-reported pain scores.   
 
Considering there are over 20,000 outpatient breast surgeries and a significant number of 
anorectal surgeries in the province of Ontario per year, the STOP Narcotics initiative could 
potentially decrease opioids and risk of opioid misuse after surgery impacting the opioid crisis in 
a truly meaningful way. 
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The Division of General Surgery established Opioid Prescribing for Acute Pain as a priority area 
for improvement by the Division of General Surgery, Schulich School of Medicine and Dentistry 
at Western University. This was based on the 2017 Health Canada – Joint Statement of Action to 
Address the Opioid Crisis and published evidence on the wide variation and excess prescription 
of opioids in general surgery.23  
 
1.7.2 ORTHOPEDIC EDUCATIONAL RANDOMIZED CONTROLLED TRIAL AT 
LONDON HEALTH SCIENCES CENTRE 
 
An RCT by Singh from the Division of Orthopedic Surgery at Western University provided the 
motivation and foundation for subsequent work on opioid reduction completed in opioid-
reduction by the Division of General Surgery.166 In 2016 this orthopedic RCT evaluated the role 
of a post-operative pain guideline pamphlet on patient’s pain satisfaction scores. While there was 
no significant difference noted in satisfaction, only 7/78 (9%) used the entire opioid prescription 
and 5/78 (6%) required a prescription refill. Despite 41 patients receiving specific instructions 
regarding disposal, only 5 patients returned their surplus medication to pharmacy.166  
 
1.7.3 DEVELOPMENT OF THE STOP NARCOTICS INITIATIVE 
 
The STandardization of Outpatient Procedure Narcotics (STOP Narcotics) initiative was 
developed in response to defining the problem of opioids in surgery and the role of the surgeon 
in the opioid crisis. This was a division-wide, multidisciplinary health systems plan that focused 
on adequately controlling patients’ pain through a multipronged approach.  
 
The STOP Narcotics initiative involved the implementation of a 4-pronged strategy: patient and 
care-giver education through counseling and written materials; health care provider education 
(surgeons, anaesthetists, residents, and nurses); intra-operative multi-modal analgesia; and post-
operative multi-modal opioid reduction strategies for pain control. The protocol was designed 
with input from relevant stakeholders (surgeons, anesthetists, nurses, and patients) and was 
instituted across the Division of General Surgery at Western University. 
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1.7.4 HERNIA REPAIR AND LAPAROSCOPIC CHOLECYSTECTOMY  
 
As part of a prior project, the STOP Narcotics initiative was implemented in a pre- and post-
intervention study including elective, outpatient laparoscopic cholecystectomy and open hernia 
(inguinal, ventral) patients. A control cohort of 224 patients was compared to a post-intervention 
group of 192 patients. Average post-operative pain scores in the pre- vs post-intervention group 
was equivalent. The multipronged intervention was associated with a 50% reduction in opioid 
prescribing with only 45% of patients filling their prescription (Table 1.2). 
 
Table 1.2 Outcomes of outpatient hernia and laparoscopic cholecystectomy  
  
Ventral/Umbilical/Inguinal Hernias and Laparoscopic Cholecystectomies 
Average pain in first 7 post-op days, mean (SD) (Equivalent reported pain NRS [1-10]) 
OME, median (50% reduction in opioid prescribing) 
Narcotic prescription filled, n (%) (Only 45% filled their prescription) 
 
1.7.5 RETROSPECTIVE REVIEW OF PRESCRIBING PRACTICES 
 
The work of this thesis on breast and anorectal outpatient surgery patients was built upon this 
foundation of the hernia and laparoscopic cholecystectomy study. To further define the problem 
in breast and anorectal surgeries, we collected data retrospectively over a 3-month time period at 
London Health Sciences Centre (LHSC) and St. Joseph’s Health Care (SJHC) examining 
prescription practices (Figure 1.3). Moderate quantities of opioid medications were being 
prescribed after these operations.  
 
 
 
Figure 1.3 
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Figure 1.3 Retrospective data of median opioid pills prescribed in 145 outpatient breast and 56 
outpatient anorectal surgeries over 3 months at LHSC and SJHC.  
 
This data was compared to Hill who quantified the average number of opioid pills prescribed 
after partial mastectomy (PM) as 20, with only 15% (3 pills) being consumed. As we were 
prescribing a median of 30 pills for PM, this confirmed overprescribing in breast surgery as this 
was roughly 10 times the amount being consumed, leaving a great amount of excess 
medication.49 These excess and variable prescriptions were paralleled in the other breast surgical 
and anorectal procedures at our institution.  
 
In further examining this retrospective data, the type of opioid medication prescribed varied 
significantly in both breast surgery and anorectal surgery, with tramacet being the most 
commonly prescribed opioid in both populations.  
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Figure 1.4 
 
 
 
Figure 1.4 Opioid prescriptions by type in 145 breast surgery patients 
 
Figure 1.5 
 
 
 
Figure 1.5 Opioid prescriptions by type in 56 anorectal surgery patients 
 
The methodology of the STOP Narcotics initiative in breast and anorectal procedure is similar to 
the previously published work in the Journal of the American College of Surgeons on 
laparoscopic cholecystectomy and hernia patients (Appendix 5.5).57 The patient care bundles 
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presented in this thesis are tailored to the breast and anorectal surgery population and their 
unique pain considerations. Therefore, expanding the work from the original STOP Narcotics 
initiative to investigate patients undergoing breast and anorectal procedures was the objective of 
this current thesis. 
 
This study was designed as a non-inferiority study for the primary outcome of pain control as we 
postulated surgeons would only change their practice if we demonstrated that there was “not 
unacceptably worse” pain control than the standard of care. A pre- and post- study is also a 
practical quality improvement design that is appropriate to use when the post-intervention group 
is not expected to change in terms of population, outcomes, or practices. As our inclusion 
criteria, surgical practices, and outcomes (e.g. patient’s rating of pain) were not expected to 
change in the post-intervention group, we proposed this design may result in less overall 
variability. Practically, a pre- and post- design also leads to a better compliance rate leading to 
more consistent interventions and practice. Considering there was a strong feeling in the 
department of general surgery that practice change in opioid prescribing needed to occur, this 
design allowed us to smoothly transition the intervention to routine practice after study 
completion.  
 
1.8 PURPOSE STATEMENT AND HYPOTHESES 
 
The purpose of the study was to modify the standardized multi-pronged, opioid-sparing, 
divisional intervention (STOP Narcotics) to adequately control post-operative pain, while 
reducing excessive post-operative opioid prescriptions in outpatient breast and anorectal surgical 
procedures.  
 
We hypothesized that with the introduction of the STOP Narcotics protocol, non-inferior pain 
control may be obtained while reducing narcotic prescriptions amongst patients undergoing these 
selected common outpatient general surgical procedures.  
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2.0 CHAPTER 2. THE STANDARDIZATION OF OUTPATIENT 
PROCEDURE (STOP) NARCOTICS AFTER ANORECTAL 
SURGERY: A PROSPECTIVE NON-INFERIORITY STUDY TO 
REDUCE OPIOID USE 
 
Hartford LB, Murphy PB, Gray DK, Maciver AH, Clarke FM, Allen LJ, Garcia-Ochoa C, Leslie 
KA, Van Koughnett JAM. 
 
2.1 BACKGROUND: 
 
Prescription opioid abuse is a major public health concern in North America, rising to one of the 
leading causes of injury-related deaths.1,2 Surgeons play a crucial role in the opioid crisis. While 
good pain control after surgery is important, post-operative prescribing of opioids after 
outpatient surgery is often excessive, and in many cases only a fraction of the prescribed opioids 
are required for adequate pain control, including after anorectal surgery.3-5 
 
Analgesia is an important aspect of surgical recovery; however, patients who are prescribed 
opioids are more likely to become chronic opioid users.6 Every refill and additional week of 
opioid use is associated with a large increase in opioid abuse in opioid naïve patients.7 In 
addition, diversion of unused prescribed medication is a significant source of abused opioids.8 
 
Anorectal surgery often requires a general anesthetic for relaxation and procedural pain control, 
but usually does not require admission to hospital.9 There are no published evidence-based 
guidelines that specifically address the appropriate amount of opioid pills to prescribe after 
outpatient anorectal procedures.10-12 However, various interventions including various oral 
medications (non-steroidal anti-inflammatory [NSAID], gabapentin, metronidazole, etc.), topical 
anesthetics, nerve blocks and intrathecal injections, and suppositories have been studied.13-21 The 
PROSPECT update on pain control after hemorrhoidectomy acknowledged that most 
recommendations are based on single-intervention smaller studies, and highlighted the 
importance of a multi-modality approach.22 
 
The Standardization of Outpatient Procedure Narcotics (STOP Narcotics) quality improvement 
initiative was developed at London Health Sciences Centre (LHSC) after identifying Opioid 
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Prescribing for Acute Pain as a priority area of focus based on the Joint Statement of Action to 
Address the Opioid Crisis, issued by Health Canada in 2017.23 We created a multi-pronged 
strategy to standardize post-operative pain management and reduce opioid prescriptions, while 
adequately controlling pain after outpatient surgery. The positive impact of the STOP Narcotics 
initiative after outpatient laparoscopic cholecystectomy and open hernia repairs was recently 
published.24  
 
This study is a prospective non-inferiority evaluation of the efficacy of the STOP Narcotics 
initiative in patients undergoing outpatient anorectal surgery, including post-operative pain 
control, patient satisfaction, and compliance. We hypothesized that the STOP Narcotics protocol 
would be associated with non-inferior pain control while reducing opioid prescriptions by 
surgeons and opioid use among patients undergoing outpatient anorectal surgery.  
 
2.2 METHODS:  
 
2.2.1 Study Design and Setting 
 
A non-inferiority, prospective pre- and post-intervention study was conducted from July 2017 to 
April 2018. Surgeries were performed at LHSC and St. Joseph’s Health Care Centre, 
encompassing 3 academic hospitals where a high volume of outpatient general and colorectal 
surgery is performed in London, Ontario, Canada. The STrengthening the Reporting of 
OBservation studies in Epidemiology (STROBE) guidelines were followed.25 Ethics approval 
was obtained through the Health Sciences Research Ethics Board at Western University 
(HSREB# 109651). 
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2.2.2 Pre- and Post-Intervention Groups 
 
To evaluate the efficacy of the STOP Narcotics initiative, adult patients aged 18 to 75 years, 
undergoing outpatient anorectal surgery, requiring an anesthetic in the operating room, were 
included in the study. Surgeries included examination under anesthesia (EUA), fistulotomy, 
seton placement, rectal advancement flap, anal dilation, transanal excision (excluding transanal 
endoscopic surgery), abscess drainage, hemorrhoidectomy and pilonidal sinus excision. Patients 
were excluded if they were known regular opioid users or had chronic pain conditions (excluding 
osteoarthritis and back pain), chronic kidney disease, or active peptic ulcer disease. Once patients 
were enrolled after an initial operation, any subsequent procedures were excluded to avoid 
duplication. 
 
A control group (pre-intervention) from July 17, 2017 to October 18, 2017 was compared to the 
post-intervention group from October 23, 2017 to April 30, 2018. The control group received 
education at the discretion of the surgeon and in the form of a written sheet, which did not 
address pain expectations or medication utilization instructions. The management of patients in 
the post-intervention group only differed by exposure to the STOP Narcotics intervention 
protocol. 
 
2.2.3 Intervention 
 
The STOP Narcotics initiative involved the implementation of a 4-pronged strategy: patient 
education through counseling and written materials; health care provider education (surgeons, 
anaesthetists, residents, and nurses); intra-operative multi-modal analgesia; and post-operative 
multi-modal opioid reduction strategies for pain control. The protocol was designed with input 
from relevant stakeholders (surgeons, anesthetists, nurses, and patients) and was instituted across 
the Division of General Surgery at Western University. The division is comprised of 20 surgeons 
who perform outpatient general surgical procedures, including 10 surgeons who performed 
anorectal surgeries during our study period. 
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2.2.4 Patient Education 
 
Patient education included four areas of focus. Verbal education for patients about pain 
expectations and discomfort after surgery was coupled with instructions for optimal utilization of 
multi-modal analgesia medications. This discussion was initiated at the time of consent for the 
procedure and reinforced on the day of surgery. Patients were given instructions on the 
appropriate use of opioids after surgery. A limited opioid prescription (10 tablets) was provided 
as a separate prescription with an expiry date of 7 days and was to be filled only if the other pain 
control strategies were deemed ineffective by the patient. Written instructions were given to sit 
in warm water 2 to 3 times per day for comfort. Healthy toileting habits, maintenance of 
adequate hydration, use of high fiber diets and fiber supplements, and optimal use of the 
prescribed laxative and other over the counter laxatives were also described to the patient to 
avoid difficult bowel movements. Patients were also educated on the appropriate disposal of 
unused medication. Instructions were reiterated on the day of operation by the surgical team and 
reviewed prior to leaving the hospital with standardized education sheets and verbal 
reinforcement by nursing staff. 
 
2.2.5 Provider Education 
 
Providers, including surgeons, anaesthetists, residents, nurses and office staff, were educated in 
large group formats (divisional rounds and meetings), written posters in clinic areas, 
electronically via email, and verbally to individuals. Education focused on the need for opioid 
reduction strategies, understanding the multi-modal analgesia initiative, and supporting patient 
and caregiver pain control expectations after surgery.  
 
2.2.6 Intra-Operative Pain Management Strategy 
 
As part of the surgical safety checklist prior to induction of anesthesia, the surgical team 
requested the provision of intravenous ketorolac (15-30 mg IV), ondansetron (4-8 mg IV), and 
dexamethasone (4-8 mg IV), to be administered by the anesthetist during the operation. The final 
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decision on intra-operative medications to be administered was left to the discretion of the 
anesthesia team.  
 
2.2.7 Post-Operative Pain Management Strategy 
 
A prescription for an NSAID (meloxicam 7.5 mg or naproxen 400 mg tablets) was given with 
instructions to use it twice a day for 72 hours. Patients also received instructions for regular use 
of acetaminophen 500 mg tablet every 6 hours for the first 72 hours. After 72 hours, patients 
were instructed to use ibuprofen 400 mg and acetaminophen 500 mg as needed for pain control. 
A separate prescription for 10 tablets of tramadol 50 mg or codeine 30 mg with an expiry date of 
7 days after surgery was provided, with specific instructions to fill this prescription only if 
adequate pain control was not achieved by the other strategies provided. Patients were also given 
a prescription for metronidazole 500 mg (1 tablet by mouth every 12 hours for 5 days) and 
polyethylene glycol (PEG) 17 g powder to be taken once to twice daily to avoid constipation and 
until stool was consistently soft (Appendix 5.2). Standardized educational materials and 
instructions on pain control strategies were distributed to patients in the recovery room, prior to 
discharge. Other post-operative instructions such as activity levels, wound care, and return to 
work were provided at the discretion of the surgeon.  
 
2.2.8 Outcomes 
 
The primary outcome was patient-reported average pain level in the first 7 post-operative days, 
measured using a modified Brief Pain Inventory Survey at their first post-operative clinic 
appointment (typically at 4 weeks post-operatively).26,27 Secondary outcomes included overall 
quality of pain management after surgery and patient function in the first post-operative week. 
The clinic survey also captured patient reported anti-inflammatory and acetaminophen use, 
filling of the opioid prescription, percentage of opioid tablets used, number of prescription refills, 
and medication disposal to a pharmacy or the outpatient clinic. In addition to self-reported 
outcomes, medical records were reviewed to identify prescriptions (all are processed and tracked 
via the electronic medical record) and post-operative complications. Oral morphine equivalents 
(OME) were calculated to quantify opioids taken (Table 2.1). 
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Table 2.1 Oral Morphine Equivalents (OME)  
 
Oral Morphine Equivalents 
10 tablets OME 
Morphine 5 mg 50 
Oxycodone 5 mg 75 
Codeine 30 mg   45 
Tramadol 50 mg 50 
Hydromorphone 2 mg 80 
 
Oral Morphine Equivalents for 10 tablets of common surgical prescriptions.  
Agency Medical Directors’ Group.27 http://www.agencymeddirectors.wa.gov/calculator/dosecalculator.htm 
 
2.2.9 Statistical Analysis 
 
The sample size was calculated based on a meaningful clinical difference (MCD) of two points 
on the numerical pain rating scale for the primary outcome.27,28 Using an alpha of 0.025, power 
of 90%, and a non-inferiority limit of two MCD points on the numeric rating scale, 44 patients in 
each of the pre- and post-intervention groups were required.  
 
All statistical analyses were performed using SPSS Version 24 (IBM Corp., SAS Institute, Cary, 
North Carolina, USA). Continuous variables were expressed as medians with interquartile ranges 
for non-normally distributed variables, and as means and standard deviations for normally 
distributed variables. Mann-Whitney U tests and independent samples t-tests were used to assess 
for differences between groups for medians and means, respectively. Chi-square tests and 
Fischer’s Exact tests were performed for categorical data. Non-inferiority was tested using the 
two-sample, equal variance, t-test for mean difference. The primary outcome was tested for non-
inferiority with a one-sided test. Two-sided tests were used for secondary variables. A p-value of 
< 0.025 for the primary outcome was considered statistically significant and p< 0.05 for 
secondary variables. 
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2.3 RESULTS:  
 
2.3.1 Study Population  
 
The study population consisted of 115 patients. In addition to the specified exclusion criteria, 10 
additional patients were excluded (Figure 2.1). After exclusion, there were 42 patients in the pre-
intervention group and 51 patients in the post-intervention groups. Pre- and post-intervention 
groups were similar in age and sex (Table 2.2).  
 
 
 
Figure 2.1 Flow chart of included patients. * N = 2 (did not complete the brief pain inventory), N 
= 5 (duplicates); ** N = 3 (duplicates) 
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Table 2.2 Patient Demographics 
 
Patient Demographics 
Pre-
intervention 
 
N = 42 
Post-intervention 
 
N = 51 
 
p-value 
Fistulotomy n (%) 15 (35.7) 22 (43.1)  
 
 
 
 
--- 
Hemorrhoidectomy n (%) 5 (11.9) 8 (15.7) 
Excision of anal lesion n (%) 6 (14.3) 4 (7.8) 
Seton placement n (%) 4 (9.5) 5 (9.8) 
Anal dilation n (%) 4 (9.5) 5 (9.8) 
Pilonidal sinus excision n (%) 1 (2.4) 3 (5.9) 
Rectal advancement flap n (%) 1 (2.4) 2 (3.9) 
Excision of rectal lesion n (%) 2 (4.8) 1 (2.0) 
Abscess drainage n (%) 2 (4.8) 1 (2.0) 
EUA n (%) 2 (4.8) 0 (0.0)  
Age in years, mean (SD) 45 (16) 44 (14) 0.67 
Male sex, n (%) 27 (64) 26 (51) 0.20 
 
EUA, Examination under anesthesia; SD, standard deviation 
* Study population after exclusion 
 
2.3.2 Patient-Reported Quality Outcomes  
 
The primary outcome of average post-operative pain score in the first 7 post-operative days was 
non-inferior in the post-intervention group compared to pre-intervention group (2.8 vs. 2.6/10, p 
= 0.33). The reported quality of pain control was not significantly different (good/very good pain 
control in 57% vs. 63%, p = 0.58). Other self-reported functional outcomes did not significantly 
change (Table 2.3).  
 
 
 
 
 
 
 
 
 55 
Table 2.3 Pre-Intervention and Post-Intervention Comparison of Pain Control 
 
Primary and Secondary Outcomes 
Pre-
intervention 
N = 42 
Post-
intervention 
N = 51 
p-
value 
Average pain in first 7 post-operative days, (n) mean (SD)                                 
All groups (0-10) 2.8 (2.1) 2.6 (2.5) 0.33 
EUA +/- seton placement (n=11) 3.3 (3.1) 2.4 (2.9) 0.31 
Fistulotomy (n = 37) 2.0 (1.6) 1.9 (1.8) 0.44 
Hemorrhoidectomy (n =13) 5 .0 (1.6) 3.1 (2.4) 0.07 
Pilonidal sinus excision or Abscess drainage (n = 7) 2.0 (2.6) 4.5 (2.5) 0.13 
Dilation, Advancement flap, Anal or rectal excision (n = 25) 2.9 (1.6) 3.1 (3.2) 0.44 
Quality of Pain Control (good/very good)    
All groups n (%) 24 (57) 32 (63) 0.58 
EUA +/- seton placement n (%) 2/6 (33) 3/5 (60) 0.57 
Fistulotomy n (%) 10/15 (67) 15/22 (68) 1.0 
Hemorrhoidectomy n (%) 2/5 (40) 2/8 (25) 1.0 
Pilonidal sinus/Abscess drainage n (%) 2/3 (67) 3/4 (75) 1.0 
Dilation, Advancement flap, Anal/Rectal lesion excision n (%) 8/13 (62) 9/12 (75) 0.67 
Patient function interference (all groups), mean (SD)    
General Activity (0-10) 5.6 (3.1) 5.3 (3.1) 0.62 
Walking ability (0-10) 4.8 (3.1) 4.3 (3.2) 0.52 
Work (0-10) 5.0 (3.2) 5.0 (3.4) 0.93 
Sleep (0-10) 4.5 (3.1) 3.5 (2.9) 0.14 
Enjoyment (0-10) 5.3 (3.2) 4.5 (3.2) 0.19 
 
All outcomes are in means; (0-10) – eleven point numeric rating scale from modified Brief Pain 
Inventory: 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-10 = severe pain; 0 = no 
interference with function, 10 = complete interference with function; Quality of pain control – 
rated from very poor to very good (five point scale).27 
 
2.3.3 Medication Related Outcomes 
 
The median OME for prescriptions filled was significantly less after the intervention (112.5 [IQR 
65-175] pre-intervention vs. 50 [IQR 50-50] post-intervention, p < 0.001) (Table 2.4). Only 
23/51 (45%) of post-intervention patients filled their opioid prescription, with no significant 
difference in prescription renewals (15.2% pre-intervention vs. 4.3% post-intervention, p = 0.20). 
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In addition, the median amount of opioids taken in the post-intervention group was reported at 
12.5 OME (2.5 pills). Appropriate excess medication disposal did not significantly differ (2/32 
[6.3%] to 4/23 [17.4%], p = 0.10), after the intervention was initiated (Table 2.4).  
 
Table 2.4 Pre-Intervention and Post-Intervention Comparison of Medications  
 
Medication Comparison 
Pre-
intervention 
N = 42 
Post-
intervention 
N = 51 
p-value 
Narcotic prescription given:    
    OME, median (25th, 75th) 112.5 (50-150) 50 (50-50) < 0.001 
    No. of pills, median (25th, 75th) 30 (10-30) 10 (10-10) < 0.001 
Narcotic prescription used:    
    OME, median (25th, 75th) 62.5 (37.5-135) 12.5 (0-46.9) < 0.001 
    No. of pills, median (25th, 75th) 15 (10-30) 2.5 (0-6.9) < 0.001 
Surgeons prescribing > median 50 OME (%) 10/13 (77) 0/10 (0) < 0.001 
Narcotic prescription filled n (%) 33/42 (79) 23/51 (45) < 0.001 
NSAID use, n (%) 15/42 (36) 28/51 (55) 0.07 
Acetaminophen use, n (%) 14/42 (33) 31/51 (61) 0.01 
Simultaneous NSAID + Acetaminophen use, n (%) 5/42 (12) 10/51 (20) 0.31 
Metronidazole prescription given, n (%) 18/42 (43) 36/51 (71) 0.01 
Laxative prescription given, n (%) 7/42 (17) 22/51 (43) 0.01 
Prescription renewal, n (%)  5/33 (15.2) 1/23 (4.3) 0.20 
Appropriate medication disposal, n (%) 2/32 (6.3) 4/23 (17.4) 0.10 
 
OME, Oral morphine equivalent; NSAID, Non-steroidal anti-inflammatory 
 
Anti-inflammatory use did not increase significantly (36% to 55%, p = 0.07), while 
acetaminophen use increased significantly (33% to 61%), p = 0.01) (Table 2.4). Metronidazole 
prescriptions increased significantly (43% to 71%, p = 0.01), as did laxative prescriptions (17% 
to 43%, p = 0.01) (Figure 2.2).  In a subgroup of hemorrhoidectomy patients, there was 88% and 
63% prescribing frequency of metronidazole and PEG, respectively, which was higher than in 
the overall group of anorectal procedures (Table 2.5).  
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Figure 2.2 
 
 
Figure 2.2 Utilization of Multi-Modal Analgesia Medications, Pre- and Post-Intervention 
 
 
Table 2.5 Pre-Intervention and Post-Intervention Comparison: Hemorrhoidectomy Subgroup  
 
Hemorrhoidectomy 
Pre-intervention 
N = 5 
Post-intervention 
N = 8 
p-value 
Narcotic prescription given:    
    OME, median (25th, 75th) 112.5 (50-150) 50 (50-50) 0.05 
    No. of pills, median (25th, 75th) 30 (10-30) 10 (10-10) 0.02 
Narcotic prescription used:    
    OME, median (25th, 75th) 168.8 (65.5 – 212.5) 18.8 (0-87.5) 0.03 
    No. of pills, median (25th, 75th) 30 (14.4 – 42.5) 3.8 (0-6.3) 0.01 
Narcotic prescription filled n (%) 5/8 (63) 6/8 (75) 1.0 
Metronidazole prescription n (%) 3/5 (60) 7/8 (88) 0.51 
Laxative (PEG or MOM) prescription n (%) 1/5 (20) 5/8 (63) 0.27 
Prescription renewal, n (%)  1/5 (20) 1/6 (17) 1.0 
 
OME, Oral morphine equivalents; NSAID, Non-steroidal anti-inflammatory 
 
2.3.4 Surgeon and patient adherence 
 
 58 
The number of surgeons prescribing greater than a median of 50 OME was eliminated (9/10 
[90%] surgeons pre-intervention vs. 0/10 surgeons post-intervention, p < 0.001). The most 
common patient-reported reasons for filling the opioid prescription were: the patient filled it just 
in case it was needed 11/23 (48%), the patient was told to fill the prescription 5/23 (22%), and it 
was needed for additional pain control 7/23 (30%). As such, only 7/51 (14%) of patients in the 
post-intervention group reported that they needed an opioid prescription for pain control (Tables 
2.4 and 2.6). 
 
Table 2.6 Post-intervention Education and Adherence 
 
Patient adherence 
Post-intervention 
N = 51 
Patients received instruction sheet, n (%) 47 (92) 
Patients found the instruction sheet helpful, n (%) 43 (86) 
Reason for filling prescription, n = 23  
Patient was told to fill it, n (%)   5 (22) 
Just in case the patient needed it, n (%) 11 (48) 
For additional pain control, n (%)    7 (30) 
 
 
2.3.5 Complications 
 
There were no documented incidents of upper gastrointestinal bleeding or renal failure in either 
the pre- or post-intervention groups.  
 
2.4 DISCUSSION:  
 
After implementation of the STOP Narcotics initiative in outpatient anorectal surgery, patient-
reported average pain scores in the first week after surgery were non-inferior to the pre-
intervention care.  Additionally, patient-rated quality of pain control was no different for all 
procedures. The STOP Narcotics intervention resulted in adequate analgesia for post-operative 
pain and significantly decreased OME prescribed and taken by patients, without an increase in 
prescription refills.  
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Standardized patient care bundles and care pathways can be successfully used to institute 
multiple evidence-based interventions in a consistent way. Our intervention consisted of a multi-
pronged approach, and similar to previous literature our opioid-reducing strategies consisted of 
patient and provider education, opioid-reduced prescriptions and multimodal non-opioid 
analgesia strategies.28-35 Verbal and written perioperative education, including clarifying patient 
expectations and providing non-opioid utilization instructions may reduce opioid use, consistent 
with our results.34  
 
An optional limited prescription of an opioid with an expiry date of 7 days was provided in our 
initiative, as a back-up for those patients requiring additional pain control. Only 45% of patients 
filled this prescription and only 14% actually filled it for additional pain control, suggesting that 
this opioid sparing strategy is effective. Providing clear instructions and expectations to patients 
was important. Two recent Cochrane Reviews suggested ibuprofen and acetaminophen may in 
fact be more effective than opioids for post-operative analgesia.31,32 While compliance with the 
analgesia protocol in our study was not 100%, these medications likely contributed significantly 
to opioid reduction. In addition, pre-emptive intra-operative analgesia with ketorolac and 
dexamethasone has been shown to decrease opioid requirements after surgery, with no increase 
in post-operative wound infection or other complications, which is consistent with the lack of 
major complications including gastrointestinal bleeding, renal failure, or thrombotic events in 
our study group.36-38 Using a patient care pathway has resulted in most patients not requiring any 
opioid prescription after anorectal surgery, in keeping with our previous work in other outpatient 
general surgical procedures.24  
 
Oral metronidazole prescriptions were given as part of our anorectal surgery electronic order set, 
with 71% of patients receiving the prescription in the post-intervention group. A recent meta-
analysis on metronidazole after hemorrhoidectomy demonstrated significantly lower reported 
pain on day 1 and 4 with significantly shorter time to return to normal activities, however, no 
difference was observed on most post-operative days.19,20 Despite this, we have elected to use it 
after anorectal surgery as part of our protocol, especially after hemorrhoidectomy, given the 
minimal side-effect profile,.  
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In the context of the current opioid crisis in North America, surgeons must recognize their role 
and act responsibly. A significant surgeon concern when prescribing less opioids may be the 
potential for an increased volume of patient calls for prescription refills, as well as decreased 
patient satisfaction. Our request for renewals was only 4.3% in the post-intervention group and 
less than previously reported by Sekhri, which is likely due to our study population of patients 
without significant chronic pain or opioid use, who were undergoing only outpatient surgeries.39 
Interestingly, it has been shown that refill requests for pain medication do not correlate with 
smaller prescription sizes and that it is very uncommon for patients to use all of tablets 
prescribed for that episode of pain.10,39  
 
Hemorrhoidectomy is often regarded as a painful surgery, ranking 23rd of 529 procedures in 
patient-reported pain for well-defined surgical procedures.40 In our study, while there was no 
significant difference in average patient-reported pain after initiation of the STOP Narcotics 
intervention, only 2/8 (25%) patients rated the quality of their pain control as “good or very 
good” in the post-intervention group (Table 2.3). This was not significantly different than the 
pre-intervention group. Despite the majority of patients filling their narcotic prescription in the 
hemorrhoidectomy group after the intervention (75%), the median amount of opioid used was 
still very low (18.8 OME or 3.8 pills). This is significantly improved from the pre-intervention 
group (median 168.8 OME or 30 pills, p = 0.03). Of note, our subset of patients undergoing 
hemorrhoidectomy was small, and our study was not powered to specifically assess the impact in 
the patients undergoing hemorrhoidectomy. This is a subgroup which likely warrants further 
research on optimization of pain control.  
 
An opioid should be only one component of pain management, and our approach is similar to the 
PROSPECT collaboration’s conclusion that a combination of oral analgesics (NSAIDs, 
acetaminophen and opioids) and local anesthetic infiltration is recommended after anorectal 
surgery.22 While not part of the data captured in our study, all 10 surgeons reported routine use 
of local anesthetic when surveyed. Opioids cause constipation, which may significantly 
contribute to pain after anorectal surgery, and thus we have included a focus on avoiding 
constipation as part of our multimodality approach. 
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Since study completion, our surgeon compliance with the STOP Narcotics care pathway has 
continued to be high. The initiative has been expanded to other procedures and other hospitals 
with positive feedback from multiple stakeholders. This is the first study in anorectal surgery 
showing that an opioid-sparing multi-modal pain management bundle is not inferior to traditional 
opioid prescribing practices. It is not, however, without limitations. There is inherent bias with 
the observational design and a randomized control trial was not performed due to a unified belief 
within the division that practice change regarding opioid prescribing was a priority. Our 
exclusion criteria are based on potential morbidities of the chosen analgesia components and 
have limited external validity. STOP Narcotics was implemented on a pre-specified date and 
there were likely some early changes in surgeon prescribing habits and patient education during 
the months before the initiative was officially implemented. Furthermore, there is variability 
between different anorectal procedures with regards to expected post-operative pain levels, and 
our study was powered to assess anorectal surgery as a single group. A future study specifically 
assessing patients undergoing hemorrhoidectomy may be useful to validate multi-modal pain 
management strategies in this subgroup. Additionally, local anesthetic and intra-operative 
medication data was not compared between the pre- and post-intervention groups, however, our 
purpose was not to evaluate their effectiveness, but to encourage their standard use. Finally, there 
was not complete compliance with the pain control initiatives by patients, nurses and surgeons.  
 
2.5 CONCLUSION:  
 
For outpatient anorectal surgeries requiring an anesthetic, a standardized care pain bundle (STOP 
Narcotics) significantly decreased opioid prescribing and often eliminated patient utilization of 
an opioid for pain control, without an increase in patient-reported post-operative pain. This was 
achieved through patient education, multi-modal opioid-sparing analgesia strategies, and focused 
systematic changes by nurses, anesthetists, and surgeons. While surgeons must consider the 
individual patent’s needs for pain control after surgery, our study shows the value and impact of 
a standardized bundle to guide the care team and patient, while reducing opioid exposure after 
anorectal surgery.  
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3.0 CHAPTER 3. THE STANDARDIZATION OF OUTPATIENT 
PROCEDURE (STOP) NARCOTICS: A PROSPECTIVE 
HEALTH SYSTEMS INTERVENTION TO REDUCE OPIOID 
USE IN AMBULATORY BREAST SURGERY 
 
Hartford LB, Van Koughnett JAM, Murphy PB, Allen LJ, Clarke CFM, Brackstone M, Gray DK, 
Maciver AH 
 
 
3.1 BACKGROUND  
 
North America has been faced with increasing dependence and misuse of prescription opioid 
medication.1,2 Women may become dependent on prescription opioid medication more quickly 
and are more at risk for overdose compared to men.3 Further, between 1999 and 2015, the rate of 
death from prescription opioid overdoses increased 471% among women, compared to a 218% 
increase among men.3 
 
Surgeons may contribute to excess opioid prescriptions; in breast surgery alone 75-85% of 
opioid prescriptions remain unconsumed.4 Recent evidence also suggests that roughly 5-15% of 
opioid naïve patients continue to use opioids regardless of whether they have undergone major or 
minor procedures.5–9 Certainly, this is relevant to breast cancer patients, considering the recent 
trend to favourable prognosis, long-term survivorship and that cancer patients are particularly 
susceptible to opioid dependence.5–9 
 
In breast surgery, there has been a shift from opioids as a primary analgesic to multimodal 
strategies.10–14 Opioid-sparing pre-emptive and post-operative pain management may include 
oral and intravenous non-opioids (such as acetaminophen, non-steroidal anti-inflammatories 
[NSAIDs], dexamethasone, gabapentin and ketamine), and local and regional nerve blocks (such 
as paravertebral and pectoral).10–13,15–19 There is limited guidance in the context of breast surgery 
on the appropriate quantity of opioid medication to prescribe, duration of use and tapering 
strategies.4,20,21  
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We identified opioid prescribing for acute pain as a priority area for improvement in our 
hospitals.22,23 Subsequently, the Standardization of Outpatient Procedure Narcotics (STOP 
Narcotics) was initiated as a health systems intervention.20 This tailored, opioid-sparing, 
multipronged strategy was developed with the objective of adequately controlling pain after 
outpatient surgery, while standardizing pain management and reducing opioid prescriptions.  
 
This study examines the effectiveness of the STOP Narcotics initiative in ambulatory breast 
surgery procedures. Breast surgery was identified as a common surgical procedure which would 
benefit from a consistent, standardized protocol due to the variation of analgesic practices and 
likely over prescription of opioids at our institution. We hypothesized that compared to 
conventional practice, this opioid-sparing strategy would provide similar pain control while also 
reducing excess prescriptions and opioid use.  
 
3.2 METHODS 
 
3.2.1 Study Design and Setting 
 
This prospective, non-inferiority pre- and post-intervention study was conducted at a single-
centre regional breast cancer care program at St. Joseph’s Health Care, in London, Ontario, 
Canada.24 The multidisciplinary surgical team is composed of five general surgeons who 
regularly perform breast surgery, and is complemented by reconstructive plastic surgeons, breast 
imaging radiologists, nurse navigators, advanced practice nurses, spiritual care providers and 
social workers.24 All breast surgery performed at St. Joseph’s Health Care is ambulatory surgery, 
with the exception of breast reconstruction. The Strengthening the Reporting of Observation 
studies in Epidemiology (STROBE) guidelines were followed.25 Ethics approval was obtained 
through the Health Sciences Research Ethics Board at Western University (HSREB# 109651).  
 
3.2.2 Pre- and Post-Intervention Groups 
 
Inclusion criteria were patients aged 18 to 75 years, undergoing ambulatory breast surgery with 
general anesthetic [partial mastectomy (PM), simple mastectomy (SM), sentinel lymph node 
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(SLN) biopsy, modified radical mastectomy (MRM), and axillary lymph node dissection 
(ALND)]. Reconstructive procedures were excluded, as these patients were admitted post-
operatively. Patients with concurrent regular opioid use, co-existing chronic pain conditions (not 
including osteoarthritis or back pain), chronic kidney disease, or active peptic ulcer disease were 
excluded. Patients from the pre-intervention group (July 17, 2017 to October 18, 2017) were 
compared to the post-intervention group (October 23, 2017 to April 30, 2018). These two groups 
differed by exposure to the STOP Narcotics protocol.  
 
3.2.3 Intervention 
 
The intervention consisted of a tailored, multipronged approach focused on four strategies: 
patient education; health care provider education; opioid-sparing pre-emptive and post-operative 
analgesia strategies. This multidisciplinary plan was created with input from surgeons, 
anesthetists, nurses and patients and was a division-wide general surgery initiative. This opioid-
sparing strategy has been previously described in outpatient laparoscopic cholecystectomy and 
hernia procedures, and specific details for this protocol in breast surgery may be found in 
Appendix 5.3, 5.4.57  
 
3.2.4 Outcomes 
 
The primary outcome was average pain on an 11-point (0-10) numeric rating scale (NRS) during 
the first 7 post-operative days.27–29 This was captured at the first post-operative appointment 
(typically 4 weeks at our institution) in a modified brief pain inventory survey.30,31 Secondary 
patient-related outcomes included overall quality of pain control [5-point scale (very poor to very 
good)] and functional outcomes [11-point NRS (0-10)].31 Medication-related outcomes included 
the following: oral morphine equivalents (OME) prescribed and used; filling of opioid 
prescription (yes/no); NSAID use; acetaminophen use; prescription refills; excess medication 
disposal. Disposal was considered appropriate if the patient returned the medication to a 
pharmacy.   
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3.2.5 Statistical Analysis 
 
The sample size was calculated by hypothesizing our primary outcome would be non-inferior 
(post-intervention) to our control group (pre-intervention). Using an α of 0.025, β of 0.1, and a 
non-inferiority meaningful clinical difference (MCD) of two on a numeric rating scale, 44 
patients per group were required in each of the pre- and post-intervention groups.32  
Statistical analysis was completed using SPSS Version 24 (SAS Institute, Cary NC, USA).33 
Mann-Whitney U test and Student’s t-test were used to assess for a difference between medians 
and means respectively. Non-normally distributed variables were expressed as medians with 25th 
and 75th quartiles, and normally distributed variables were assessed using means and standard 
deviations. Chi-squared was used to assess differences in categorical variables. Non-inferiority 
was tested using the two-sample, equal variance, t-test for mean difference. Only our primary 
outcome was tested for non-inferiority with a one-sided test, with a p-value of < 0.025 
considered significant. All other secondary variable were two-sided tests with a p-value of < 0.05 
considered significant.  
 
3.3 RESULTS 
 
3.3.1 Study Population  
 
After exclusion, the study population consisted of 173 patients (85 pre-intervention, 88 post-
intervention), with a lower age in the post-intervention group (59 vs. 53 years, p = 0.004), (Table 
3.1). There were 7 patients excluded for additional reasons not specified in the exclusion criteria, 
as outlined in Figure 3.1. 
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Figure 3.1 
 
 
Figure 3.1 Flow chart of included patients. * N = 1 (did not complete the brief pain inventory); 
**N = 6 (3 did not complete the brief pain inventory and 3 were inpatient procedures).  
 
Table 3.1 Patient Characteristics 
 
Patients & Procedures 
Pre-Intervention 
N=85 
Post-Intervention 
N=88 
 
p-value 
Partial mastectomy  28 (33%) 29 (33%) -- 
Simple mastectomy  8 (9%) 5 (6%) -- 
PM and SM  36 (42%) 34 (39%) -- 
PM + SLN biopsy 33 (39%) 33 (38%) -- 
SM + SLN biopsy 12 (14%) 8 (9%) -- 
PM and SM + SLN biopsy 45 (53%) 43 (49%) -- 
MRM 1 (1%) 6 (7%) -- 
PM + ALND 1 (1%) 2 (2%) -- 
ALND  2 (2%) 3 (3%) -- 
MRM and ALND 4 (5%) 11 (13%) -- 
Age (years), mean (SD) 59 (14) 53 (14) 0.004 
Female sex  85 (100%) 88 (100%) 0.33 
 
PM, Partial Mastectomy; SM, Simple mastectomy; SLN, Sentinel lymph node biopsy; MRM, 
modified radical mastectomy; ALND, axillary lymph node dissection; SD, standard deviation 
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3.3.2 Primary Analgesia Outcome and Quality of Pain Control 
 
After implementation of the STOP Narcotics initiative, the primary outcome of average pain in 
the first 7 post-operative days was non-inferior to the control group (2.0/10 pre-intervention vs. 
2.1/10 post-intervention, p = 0.40). This was comparable in the subgroup populations of PM/SM, 
SLN, or ALND patients when analyzed separately, (Table 3.2). Similarly, quality of pain control 
was not significantly different in any breast procedures (good/very good quality, 85% pre-
intervention vs. 88% post-intervention, p = 0.60), or in the subgroup populations. Other 
functional self-reported outcomes did not significantly change, (Table 3.2). 
 
Table 3.2 Pre- and Post-Intervention Comparison of Pain, Quality, and Function 
 
Primary and Secondary Outcomes 
Pre-
intervention 
N = 85 
Post-
intervention 
N = 88 
p-value 
Average pain in first 7 post-operative days, mean (SD)  
All groups (0-10) 2.0 (1.8) 2.1 (1.6) 0.40 
PM and SM (0-10) 1.9 (1.8) 1.6 (1.3) 0.26 
PM and SM + SLN (0-10) 2.1 (1.8) 2.4 (1.7) 0.20 
MRM and ALND (0-10) 2 (2.2) 2 (1.9) 0.50 
Quality of Pain Control (good/very good)    
All groups 72 (85%) 77 (88%) 0.60 
PM and SM 29 (81%) 32 (94%) 0.09 
PM and SM + SLN 39 (87%) 36 (84%) 0.70 
MRM and ALND 4 (100%) 9 (82%) 0.36 
Patient function interference (all groups), mean (SD)   
General Activity (0-10) 3.3 (3.0) 3.9 (2.7) 0.17 
Walking ability (0-10) 1.5 (2.6) 1.2 (2.1) 0.28 
Work (0-10) 3.2 (3.2) 3.7 (3.3) 0.32 
Sleep (0-10) 3.4 (2.9) 2.7 (2.5) 0.07 
Enjoyment (0-10) 2.9 (3.0) 2.6 (2.6) 0.47 
 
All outcomes are in means; (0-10) – eleven-point numeric rating scale from modified brief pain 
inventory: 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-10 = severe pain; Quality of pain 
control – rated from very poor to very good (five-point scale); 0 = no interference with function, 
10 = complete interference with function.27-29  
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3.3.3 Opioid Prescriptions and Utilization 
 
Median OMEs and pills prescribed decreased from 100 OME (25 pills) pre-intervention vs. 50 
OME (10 pills) post-intervention, (p < 0.001). Patients consumed a median of 33.8 OME (7.5 
pills) pre-intervention vs. 12.5 (2.5 pills) post-intervention, (p = 0.002 and p = 0.007, 
respectively). In the post-intervention group, only 39/88 (44%) of patients filled their opioid 
prescription, compared to 64/75 (85%) pre-intervention (p < 0.001). Of the patients who filled 
their opioid prescription in the post-intervention group, 8/88 (9%) patients reported filling it for 
pain not satisfactorily controlled with initial non-opioid alternative measures. The most common 
reason for filling the rescue opioid prescription was “just in case” (21 patients), followed by the 
patient being “instructed to fill it” (10 patients), (Table 3.3). 
 
Table 3.3 Pre- and Post-Intervention Comparison of Medication  
 
Medication Comparison 
Pre-intervention 
N = 85 
Post-intervention 
N = 88 
p-value 
Narcotic prescription given:    
    OME, median (25th, 75th) 100 (68-135) 50 (50-106) < 0.001 
    No. of pills, median (25th, 75th) 25 (15-30) 10 (10-20) < 0.001 
Narcotic prescription used:    
    OME, median (25th, 75th) 33.8 (14-75) 12.5 (0-50) 0.002 
    No. of pills, median (25th, 75th) 7.5 (3.2-15) 2.5 (0-9.4) 0.007 
Surgeons prescribing > median 50 OME  4/5 (80%) 1/5 (20%) 1.0 
Narcotic prescription filled * 64/75 (85%) 39/88 (44%) < 0.001 
NSAID use 30 (35%) 53 (60%) 0.001 
Acetaminophen use 54 (64%) 66 (75%) 0.10 
Simultaneous NSAID + Acetaminophen use 19 (22%) 50 (57%) <0.001 
Prescription renewal* 3/75 (4%) 2/88 (2%) 1.0 
Appropriate medication disposal** 6/50 (12%) 6/29 (21%) 0.04 
 
OME, Oral morphine equivalent; No., Number; NSAID, Non-steroidal anti-inflammatory; * 
different denominator as not all patients received an opioid prescription; ** different 
denominator as only included patients which did not use 100% of their opioid prescription 
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3.3.4 Analgesic Non-Opioid Adjuncts and Medication Disposal 
 
Patients’ use of NSAIDs increased in the post-intervention group from 35% to 60%, (p = 0.001), 
whereas acetaminophen use (64% to 75%) was not statistically significant (p = 0.10). 
Appropriate medication disposal increased from 12% to 21% (p = 0.04), (Table 3.3). 
 
3.3.5 Subgroup Population Analysis 
 
In the subgroup population of SM/PM, SLN, and ALND, OMEs/pills prescribed decreased 
significantly in all groups, with the exception of ALND [135 OME (36 pills) pre-intervention vs. 
50 OME (10 pills) post-intervention, (p = 0.08)]. In procedures including axillary surgery, these 
patients did not fill their opioid prescription more frequently than breast surgery alone [SM/PM 
= 9/34 (26%) vs. SLN = 23/43 (53%) and ALND = 6/11 (55%), (p = 0.07)] or consume 
significantly more opioid pills [SM/PM 1.3 pills vs. SLN and ALND 2.5 pills, (p = 0.63)], (Table 
3.4). 
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Table 3.4 Medication Comparison in PM/SM, PM/SM + SLN, and ALND/MRM  
 
Medication Comparison 
Pre-intervention 
N = 85 
Post-intervention 
N = 88 
p-value 
PM and SM N = 36 N = 34  
Narcotic prescription given:    
    OME, median (25th, 75th) 75 (56-135) 50 (50-98) 0.016 
    No. of pills, median (25th, 75th) 19 (15-30) 10 (10-16) 0.008 
Narcotic prescription used:    
    OME, median (25th, 75th) 30 (14-75) 6 (0-50) 0.091 
    No. of pills, median (25th, 75th) 7.5 (3.8-15) 1.3 (0-8.1) 0.062 
Narcotic prescription filled  27 (84%) 9 (28%) <0.001 
PM and SM + SLN  N = 45 N = 43  
Narcotic prescription given:    
    OME, median (25th, 75th) 100 (75-135) 50 (50-113) 0.033 
    No. of pills, median (25th, 75th) 25 (20-30) 10 (10-30) 0.011 
Narcotic prescription used:    
    OME, median (25th, 75th) 38 (14-75) 13 (0-50) 0.066 
    No. of pills, median (25th, 75th) 7.5 (3.4-15) 2.5 (0-10) 0.030 
Narcotic prescription filled  33 (85%) 23 (54%) 0.002 
ALND and MRM N = 4 N = 11  
Narcotic prescription given:    
    OME, median (25th, 75th) 135 (113-208) 50 (50-50) 0.08 
    No. of pills, median (25th, 75th) 36 (30-55.5) 10 (10-10) 0.03 
Narcotic prescription used:    
    OME, median (25th, 75th) 20 (0-94) 13 (0-38) 0.79 
    No. of pills, median (25th, 75th) 5.25 (0-25) 2.5 (0-7.5) 0.65 
Narcotic prescription filled  4 (100%) 6 (55%) 0.10 
 
PM, Partial mastectomy; SM, Simple mastectomy; SLN, Sentinel lymph node biopsy; MRM, 
Modified radical mastectomy; ALND, Axillary lymph node dissection; SD, Standard deviation; 
OME, Oral morphine equivalents; NSAID, Non-steroidal anti-inflammatory 
 
3.3.6 Patient and Surgeon Compliance 
 
Patients reported receiving the education sheet 92% of the time, with 88% confirming it to be 
helpful. Surgeons prescribing greater than 50 OMEs for breast procedures decreased from 4/5 
(80%) to 1/5 (20%).  
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3.3.7 Complications 
 
There were no documented incidents of upper gastrointestinal bleeding or renal failure in either 
cohort. There were no reports of skin flap necrosis or other known complications from topical ice 
therapy.  
 
3.4 DISCUSSION  
 
The major findings from this study are three-fold: first, after implementation of a multi-pronged, 
opioid-sparing initiative (STOP Narcotics), control of acute post-operative pain in the first 7 days 
was not inferior to pre-implementation practice. Second, patient education, health care provider 
education, opioid-reduced prescriptions, and multimodal non-opioid analgesic strategies were 
reaffirmed to be effective in significantly reducing both prescribed and consumed 
opioids.11,13,17,34-38 Finally, these strategies may be integrated effectively into a perioperative pain 
control bundle, and implemented as a health systems intervention for outpatient breast 
procedures.36,37,39-41  
 
Our findings have important implications. Common reasons from providers for large opioid 
prescriptions are the minimization of refill requests and ensuring adequate analgesia. While our 
inclusion criteria included elective, low risk patients, refill requests did not correlate with 
prescription strength or amount, similar to other studies.26,38,42 Our study also affirms that actual 
amount of opioid consumed is often a fraction of that which is prescribed.43 Indeed, only 44% of 
patients filled their rescue opioid prescription, consuming a median of 7.5 opioid pills and 2.5 
opioid pills in our pre- and post-intervention groups respectively. This is similar to findings of 
Hill et al, who reported patients only used 14.7% of their opioid prescription following partial 
mastectomy and 25.7% after SLN biopsy.4,44-46 Considering the average pain score was 2.0 and 
2.1 in our pre- and post-intervention group (threshold for moderate pain ≥ 4/10 on the 11-point 
NRS), the minimal amount of opioid consumed is providing adequate analgesia.32,47,48 Surgeons 
may not be providing realistic expectations of postoperative discomfort, and underestimating the 
effectiveness of opioid-sparing, multimodal analgesic medications, often reported to be equally 
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effective in the literature.49,50 In fact, rescue opioid therapy was only needed in 8/88 (9%) of our 
patients, for discomfort not adequately controlled with acetaminophen, NSAIDs, and 
conservative measures.  
 
A rescue opioid prescription with an expiry date of 7 days was a novel component of the STOP 
Narcotics initiative, preventing excess and unused medication available for unintended purposes 
in the future.26 This is in keeping with recent breast surgery guidelines supporting non-opioid 
multimodal analgesia with rescue opioids if needed.10,51 With only 9% of patients filling the 
rescue prescription for “additional pain control”, the most common reason patients filled the 
prescription was “just in case” (24%) or the patient “was told to fill it” (11%). This may be 
related to inadequate access to a 24-hour pharmacy or advice of pharmacists. There was no data 
collected on patient geography to confirm this. Despite specific written instructions, appropriate 
medication disposal only increased to 21%, consistent with other published interventions.26,52,53 
Future studies are indicated to assess methods that will improve rates of appropriate narcotic 
disposal.26,52,53  
 
Procedures involving the axilla, particularly ALND, are associated with greater discomfort and 
higher rates of chronic pain.54 There was no significant difference in average patient-reported 
pain post SLN biopsy or ALND in our post-intervention group in the first 7 post-operative days. 
Despite more patients filling their prescription in the SLN and ALND subgroups, the amount of 
reported opioid consumed was still very low (12.5 OME). With more extensive dissection in a 
highly innervated area, and with a higher risk of chronic pain syndromes and mobility 
complications, future studies with larger populations and longer follow up may be indicated to 
further define additional analgesic adjuncts for these procedures.  
 
In accordance with previous studies, patient and provider education are key opioid-reducing 
modalities.34,35 Complete elimination of pain is not a reasonable expectation, and a mild amount 
of discomfort is normal and should be expected by patients.20 Katz et al. demonstrated how pre-
operative anxiety was an important variable contributing to the prediction of acute pain after 
surgery.55 We believe a short conversation between the patient and the caregiver with the health 
care provider about expectations, the recovery process, and optimal use of non-opioid 
 76 
medication, reinforced with a standardized education sheet was key in this initiative.56 Providers 
need to be educated on the actual amount of opioid patients consume after breast surgery, non-
opioid analgesic options, and how to well-inform their patients of analgesia options.35  
 
This study has many strengths including being one of the first published multi-pronged, opioid-
sparing pain care bundles to be introduced in breast surgery, and is replicable for other health 
systems.26,40 However, it is not without limitations. There was a difference in patient age 
between pre/post-implementation periods where patients in the latter were younger. We believe 
this was due to chance and it is unlikely to impact our outcome, post-operative pain. There is 
inherent bias with an observational pre-/post study design. With this design practice may have 
changed prior the official implementation of the intervention. However, if this occurred it would 
underestimate the change in prescribing, as retrospectively surgeons were prescribing even 
higher quantities of opioids. Another limitation is single-centre data with sequential enrollment 
of patients and potentially limited external validity in other centres and in patients who do not 
meet inclusion criteria. However, with lower rates of resident turnover and variability in non-
academic centres, we believe it may be equally effective in those settings. We have implemented 
STOP Narcotics in additional community hospitals and continue to collect data from these 
centres. Further work in analysis of findings from STOP Narcotics protocol in other communities 
will further inform the generalizability of this work. It is important to note that although local 
anesthetic field blocks were not part of the official STOP Narcotics protocol, they are used 
regularly by all five surgeons. Extended-release local anesthetic and additional non-opioid co-
analgesics could be added to future studies and could also be incorporated into a similar protocol.  
 
Considering there are over 20,000 outpatient breast surgeries in the province of Ontario per year, 
the STOP Narcotics initiative could potentially decrease opioids after surgery from 500,000 to 
88,000 pills. 
 
3.5 CONCLUSION  
 
Adequate analgesia may be obtained for outpatient breast surgery, using a multipronged pain 
care pathway targeting patient and provider education, as well as multimodal, opioid-sparing 
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intra- and post-operative analgesia strategies (STOP Narcotics initiative). Opioid use can be 
significantly reduced and often eliminated when used as rescue therapy. A culture shift is needed 
in order to implement non-opioid alternatives as the foundation of pain management for 
outpatient surgical breast procedures. This initiative may be replicable at a health systems level 
and provide a framework for future analgesia guidelines in ambulatory breast surgery.  
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4.0 CHAPTER 4 DISSCUSSION AND DISSEMINATION 
 
4.1 SUMMARY OF MAJOR FINDINGS 
 
The major findings from the study of both the outpatient breast and anorectal surgery populations 
are as follows: First, patient-reported pain was non-inferior and adequately controlled after 
implementation of this multipronged, opioid-sparing intervention. Second, patient and provider 
education, multimodal non-opioid analgesic medications and opioid-reduced prescriptions were 
reaffirmed to be effective as opioid-reducing interventions. They were feasibly combined 
together as bundle and implemented at a health-systems level. Third, we reaffirmed that when 
opioid-reduced or opioid-rescue prescriptions were filled, that actual opioid consumption was 
still low, with no increase in prescription refills. Finally, we again confirmed that appropriate 
medication disposal increases with specific instructions; however, overall still remains quite low.  
 
4.1.1 Patient-reported pain after surgery 
 
 . This patient-centred primary outcome of average pain was reported on a 11-point numeric 
rating scale (0-10) which was completed at the first post-operative appointment. We showed 
similar levels of pain control that were non-inferior in the pre- and post-intervention group [(2.0 
vs 2.1/10, p = 0.40, breast surgery) and (2.8 vs 2.6/10, p = 0.33, anorectal surgery)]. 
Furthermore, with the NRS, pain levels are generally interpreted as 0 = no pain, 1-3 = mild pain, 
4-6 = moderate pain, 7-10 = severe pain. As both anorectal and breast surgery levels were rated 
between 2-3/10 and a level of 4/10 is defined as inadequate analgesia, we believe that not only 
was non-inferior pain demonstrated but that pain was indeed adequately controlled in both 
groups.  
 
4.1.2 Patient education 
 
Pain is defined by the International Association for the Study of Pain (IASP) as including two 
components. First, there is ‘the objective, physiologic and sensory aspects’ but there is also the 
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‘subjective, emotional and psychological components’.1 As anxiety and emotional status are 
important predictors of post-operative pain, education targeting clarification of patient 
expectations and providing clear analgesic instructions are key factors in managing post-
operative pain.2–6 This is consequential considering the increasing complexity of surgery and 
analgesic options.  
 
While adequate analgesia is critical, patients need to understand complete elimination of pain is 
not a reasonable expectation, and a mild amount of discomfort is normal post-operatively.  
We believe that our study reaffirms that both verbal and written instructions along with 
clarification of patient expectations are important aspects of peri-operative care, and likely 
contributed to overall patient satisfaction and opioid-reduction.  
 
There was variability in who gave the verbal instructions in our group, and this was not captured 
and the effect of this is unknown. While often it was a general surgeon or surgical resident, there 
may have other times where a nurse or non-surgical resident were giving the instructions. In 
particular, the recovery room and day surgery nurses were key in reviewing the written 
instructions with patients. There was positive feedback from the nurses as the variability of 
instructions between different surgeons had decreased with the standardized education sheets.  
 
4.1.3 Provider Education 
 
The opioid crisis partially stemmed from providers being educated that pain was “the fifth vital 
sign” and that pain was undermedicated with underestimation of the addiction potential of 
opioids. Unfortunately, we now need to “undo” this education partially and “re-educate” 
providers on appropriate opioid prescribing practices and multimodal analgesia.  
 
Buy-in of the surgeons, anesthetists and entire care team was central to the success of the STOP 
Narcotics initiative. This allowed change at a health systems level, which is arguably the most 
effective of all opioid-reducing interventions.  
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Our study corroborated Wetzel and Howard, reaffirming provider education to be an effective 
opioid-reducing strategy.78 During provider education, feedback was obtained and questions 
were answered surrounding the STOP Narcotics protocol, which likely assisted with compliance 
at the departmental level. 
 
Even prior to implementation of the intervention in this pre- post study, opioid prescribing 
decreased from a median of 30 pills in the retrospective data to 20 pills in the pre-intervention 
group. This was likely due to increased conversation about the opioid crisis among the care team, 
discussion of the upcoming pre- and post-intervention study and re-emphasizes the significance 
of surgeon buy-in and education.  
 
Evidence for opioid-reduction needs to be presented to the entire care team (surgeons, 
anesthetists, residents, preadmission clinic (PAC) staff and nurses, post-anesthesia care unit 
(PACU) nurses and day surgery nurses) as these members all have an integral role in patient care 
and pain management.  
 
We found the most effective education material was based on the following: a) discussing the 
history of the opioid crisis; b) explaining why the surgeon and care team have a role; c) 
discussing evidence-based methods of opioid-reduction and multimodal analgesia; d) addressing 
common concerns – often surrounding prescription refill requests and concerns for inadequate 
quantity of opioid providing poor analgesia.  
 
Provider education is fundamental and should be the first step in the approach to reducing opioid 
use as it allows for organizational change and simultaneous development of a multimodal 
comprehensive pain regimen for patients at the institution.  
 
4.1.4 Intra- and post-operative medication utilization and prescribing.  
 
A limited supply of opioids in the form of an opioid “rescue” or “optional” prescription was 
utilized in this study. An expiry-date of 7 days prevented the filling of the prescription for 
potential later use. A quantity of 10-opioid pills was chosen as a guideline for these 
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prescriptions. This was based on previous studies examining the amount of opioid patients 
consume after outpatient surgery.910 Our study confirmed that in patients who filled their 
prescription the amount of opioid consumed was small (4 pills) in the post-intervention group. 
Indeed, the majority of patients (55%) did not fill their opioid prescription.  
 
An opioid-rescue prescription was utilized in the intervention. If the patient did not live near a 
pharmacy, there was a discussion between the provider and the patient as to whether the 
prescription should be filled immediately. We believe this approach was appropriate due to 
recent guidelines promoting rescue-opioid therapy, in addition to evidence demonstrating 
equivalent analgesia with non-opioid multimodal measures.81112–14 
 
The anesthesia department collaborated on this multidisciplinary plan and were consistently 
supportive of the STOP Narcotics initiative. The intra-operative protocol recommendations of 
ketorolac, dexamethasone and ondansetron are based on level 1 evidence and were 
recommended by our anesthesia department. We did not collect data on the adherence to these 
recommendations, due to strong current evidence for their use. As well, the majority of our 
anesthetists reported using these medications routinely prior to the study. Anesthetists have an 
integral role, especially in controlling immediate post-operative analgesia. We found a short 
conversation occurring between the anesthetist and surgeon about the intra- and post-operative 
analgesia plan and the appropriateness of the NSAIDs in the patient was beneficial in providing a 
comprehensive analgesic plan for each patient.  
 
A prescription for a NSAID was given post-operatively to be used regularly for 72 hours. 
Meloxicam, which is not an over-the-counter medication in Canada, was routinely used to 
promote patient compliance. In addition, a prescription NSAID may have additional placebo 
benefit, however, more evidence is needed to elucidate if this is indeed true. The cost of 6 pills 
(72 hours) of meloxicam is approximately $3.00 CAD, which is similar to over the counter 
ibuprofen or naproxen, although there is a pharmaceutical dispensing fee associated with this. 
There was not a significant number of voiced complaints from patients expressing concern due to 
the expense of this prescription. Although over-the-counter naproxen was an option in the STOP 
Narcotics protocol this was utilized by very few surgeons and patients.  
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Only 44% and 45% of patients in the breast and anorectal surgery groups filled their rescue-
opioid prescription. Only 9% of the entire population reported filling it for pain not satisfactorily 
controlled with regular acetaminophen and NSAIDs. This corroborates evidence that NSAIDs 
and acetaminophen are effective in post-operative analgesia. Indeed, meta-analyses by the 
Cochrane Database indicated that ibuprofen and acetaminophen together may be more effective 
than opioids for acute post-surgical pain.12,13 Compliance of taking NSAIDs with acetaminophen 
in our study was not 100% and we did not investigate why some patients were non-adherent to 
the protocol. Possibilities include minimal pain not requiring additional analgesia, an intolerance 
to the medication or simply non-adherence. There is level 1 evidence for these medications in the 
peri-operative period and they should be routinely used for patients without contraindications.  
 
We utilized dexamethasone, acetaminophen, NSAIDs and opioid-rescue prescriptions in our 
opioid-sparing multimodal analgesic strategy. While not part of the data captured, all surgeons at 
our institution reported routine use of local anesthetic when surveyed. In addition, metronidazole 
and polyethylene glycol (PEG) were used in the anorectal group. Conservative measures 
included ice therapy in the breast surgery group and sitz baths in the anorectal surgery group. All 
these interventions were implemented based on evidence and recommendations from our general 
surgeons and anesthetists. Other medications such as NMDA antagonists, Alpha-2 agonists, 
gabapentinoids, selective serotonin reuptake inhibitors, and tricyclic antidepressants were not 
added to the protocol due to side effect profile, insufficient evidence and minimal analgesic 
benefit.  
 
We designed our multimodal intra- and post-operative analgesic regimen to be focused on 
maximizing the pharmacologic benefits, while minimizing adverse effects.15 This can be 
accomplished through the combination of different mechanisms of actions of analgesic drugs that 
have additive, if not synergistic effects, facilitating the recovery process. These various 
medications and interventions need to be safe, simple, and cost-effective.  
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4.1.5 Standardized pain care bundle 
 
“Standardized patient care bundles” are increasingly utilized as methods to implement multiple 
evidence-based interventions for quality improvement initiatives on a large scale. While every 
patient requires an individualized approach, our study has shown the value of a standardized 
bundle to guide surgeons, anesthetists and nurses in providing a comprehensive pain 
management strategy while reducing opioids in this population. Development of a “pain care 
bundle” should be a central component to new care pathways, focusing on the minimization of 
opioid use, and multimodal analgesia 
 
Indeed, while education of the entire care team is important, STOP Narcotics reaffirmed the 
value of introducing a protocol or guideline at a divisional level. While there is always crossover 
between written guidelines and provider education, implementing change in the form of a 
“bundle” at an organizational or departmental level provides the foundation for institutional 
change.  
 
4.1.6 Prescription refills 
 
A concern of surgeons is often increased phone calls for prescription renewals after surgery. Our 
results demonstrate there was no difference in prescription requests which remained quite low. 
This was consistent with another study evaluating an intervention in 246 patients where opioid 
prescribing decreased by 53%. Refill requests did not change and were required in only 0.4% of 
patients.16 After reducing opioid prescriptions by 38% Howard also demonstrated prescription 
refills did not change significantly from 4.1% to 2.5%.17 Sekhri examined probability of 
prescription refill in 26,520 opioid naïve patients who underwent major or minor surgical 
procedures.18 There were 8.7% of patients who filled their prescription, however, the probability 
of a refill did not correlate with quantity of opioid prescribed.18  
 
With a movement to opioid-rescue prescriptions or potentially discharging a patient without an 
opioid prescription, there is need for more research on methods to provide a limited supply 
opioid prescription more conveniently and efficiently if needed.  
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4.1.7 Excess medication disposal 
 
Even with specific instructions appropriate disposal of excess medication to a pharmacy 
increased but was still quite low in our study. With Hill reporting only 28% of opioid 
prescriptions being consumed, considering there are over 50 million ambulatory procedures in 
the United States alone, this truly may contribute to an astounding quantity of leftover opioid 
medication. Data from the National Survey on Drug Use and Health indicates that prescription 
opioids for non-medical use are most commonly obtained from a friend or relative in the 
majority of cases. Potential solutions for the tremendous amount of leftover medication and 
disposal techniques are areas we have identified for future study at our institution.  
 
4.1.8 Compliance 
 
We established the role of the surgeon on account of the misuse of prescription opioids, the risks 
of chronic opioid use, the current practice of variable and excessive opioid prescriptions and the 
need to instruct the patient on appropriate disposal of excess medication.  
 
A major limitation to the study was the lack of data as to why some patients and staff were non-
compliant with the protocol. Therefore, after study completion, we distributed a survey to gather 
information from surgeons, residents and office administration to gather feedback regarding 
compliance to the study. We used medication and prescription compliance as an indirect marker 
of patient and surgeon compliance.  
 
4.1.9 Patient compliance 
 
Patients’ use of acetaminophen and NSAIDs increased significantly with a prescription NSAID 
and instructions its utilization. When considering all groups compliance was 70% for NSAIDs 
and 79% for acetaminophen. Medication utilization may be a poor marker for compliance as 
patients who had very minimal or no pain may not have felt the need to take the medication.  
When asked why patients in our cohorts filled the rescue-opioid prescription the most common 
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reasons were “just in case” or “I was instructed to fill it”. The majority of patients (94%) did find 
the written instructions helpful.  
 
We did not examine the data for geographic distribution of patients or examine the 
socioeconomic status of those who filled their prescriptions. We do know from previous data that 
lower socioeconomic status is a risk factor for misuse of opioids. In particular, the relationship of 
patients who are filling or not filling their rescue opioid prescription may be correlated to their 
geography and socioeconomic status, particularly if they lived further away from a 24-hour 
pharmacy. While this was not a focus of our study, it is an area that may benefit from further 
study. 
 
4.1.10 Surgeon compliance 
 
All but one of the 20 surgeons at our centre changed their opioid prescribing habits. In following 
prescriptions over 1-year, ongoing compliance and use of the STOP Narcotics initiative in 
outpatient procedures remains high, and knowledge translation has been witnessed into other 
procedures not included in the study such as thyroidectomies, laparoscopic appendectomies and 
other more minor outpatient procedures. When surveyed, the respondents stated they discussed 
pain control with their patients “usually” or “always” 9/17 (53%) in clinic and 15/17 (88%) on 
the day of surgery. The majority of the surgeons and residents found the post-operative plan on 
our EMR helpful and easy to use. The surgical residents wrote the majority of prescriptions and 
reported using the post-operative plan without exception. All surgeons subjectively noticed no 
difference in phone calls, with the exception of two surgeons (one noticed a decrease and another 
an increase).  
 
4.1.11 Office administration 
 
All executive office administration staff reported no subjective difference in phone calls from 
patients, with the exception of three (one reporting an increase and two reporting a decrease) 
when surveyed.  
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4.1.12 Nursing compliance 
 
As the previous culture at our institution was for every adult patient to receive an opioid 
prescription after surgery, initially day surgery nurses were instructing patients to fill their rescue 
opioid prescription immediately. Currently, more than a year after implementation of STOP 
narcotics our day surgery team is very proud of the role they play and have been involved in 
making educational videos for other institutions, clearly explaining the concept of the opioid-
rescue prescription and multimodal analgesia. Interestingly, one factor for which they have 
expressed ongoing satisfaction is that in standardizing the post-operative pain care protocol, 
variability in the many written instructions provided by different surgeons has been virtually 
eliminated.   
 
4.1.13 Limitations 
 
While our study has many strengths, it is not without its limitations. With a prospective, 
observational pre- and post-study there is inherent bias, and with access to retrospective data, we 
know practice change occurred prior to the implementation date of the intervention. This results 
in an overall underestimation of the already significant reduction in opioid prescribing. It also 
emphasizes the significant impact of organizational interventions such as guidelines and provider 
education.  
 
As this was completed at an academic centre, there is limited external validity with our inclusion 
criteria. However, with lower rates of resident turn-over and variability in non-academic centres, 
it is reasonable to hypothesize this may be successful in the community setting. After study 
completion we implemented this intervention in two regional community hospitals and although 
most follow-up data was subjective, there were no reports of inferior analgesia from nurses or 
patients, and positive feedback from nursing was received about standardizing instructions and 
practice among surgeons. While this is an area for ongoing research, an identified difficulty was 
having patients complete the modified brief pain inventory survey in a busy surgical clinic to 
retrieve objective outcomes data.  
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There is also limited external validity in regards to other procedures. Although we did not 
include other minor surgeries in our inclusion criteria, we witnessed spillover into other 
procedures and believe that with small adjustments it may be successful in other surgical 
procedures and specialties.  
 
It is difficult to determine causation in a prospective cohort, non-inferiority study. The purpose 
of this study was not to demonstrate the effectiveness of any specific intervention or medication, 
as an RCT would be a better model for this. Rather, our purpose was to combine multiple 
evidence-based, opioid-sparing modalities into a standardized bundle and implement this at a 
health systems level. It was not feasible to randomize some elements of intervention such as 
health care provider education. Indeed, it was also not ethical to compare the intervention to 
placebo or no pain control. If we randomized the intervention to the “standard of care” from 
retrospective data we knew this was extremely variable. Additionally, this was not designed as 
an RCT due to a unified belief within the division of general surgery that practice change 
regarding opioid prescribing was excessive and change needed to occur. There was also concern 
this pre-existing bias among the surgeons may affect whether the randomization process would 
be followed appropriately. Additionally, with the intervention implemented at a single point in 
time, this may have resulted in less variability in surgeons, residents, and nurses as the inclusion 
criteria, surgical practices, and outcomes such as breast or anorectal pain did not change over 
time.  
 
The primary outcome of average pain in the first 7 post-operative days was determined at the 
first post-operative appointment, typically four weeks at our institution. This provides an 
opportunity for recall bias to affect our outcomes. However, both the pre- and post-intervention 
groups would have had equal exposure to this bias. In addition, patient-reported pain was not just 
statistically non-inferior but was very similar in both groups. 
 
The post-intervention group received additional instructions and may have been more aware of 
our efforts to decrease opioid prescribing. This may have resulted in bias known as the 
Hawthorne effect – where patients altered their behavior or survey inputs due to their awareness 
of being observed. This bias may likely minimal as both the pre- and post-intervention patients 
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were consented, aware of the research topic, filled out the modified brief pain inventory, and 
were unaware of whether they were part of the pre- or post-intervention group  
 
Our sample size was adequately powered to assess breast surgery and anorectal surgery 
outpatient procedures as one group. However, within these procedures there were subgroups and 
associated variability with regards to expected post-operative pain levels. Some of these 
subgroups such as axillary lymph node dissection (ALND) or hemorrhoidectomy patients did not 
reach statistical power, and therefore we cannot reach conclusions in these small groups of 
patients. Future studies, that examine these subgroups may be useful to design multimodal 
analgesic strategies specific to these procedures.   
 
While not part of the data captured, all surgeons at our institution reported routine use of local 
anesthetic when surveyed. In addition, liposomal bupivacaine for possibly more extended 
analgesia was not available at the time of this study in Canada. Finally, our study does not 
demonstrate perfect compliance by patients, nurses or surgeons. Early in the intervention some 
perioperative nurses were still instructing patients to fill their rescue-opioid prescription which 
was contrary to the patient education given. One surgeon also did not change his/her practice 
with quantity of OME actually increasing in the post-intervention group. All these patients were 
included however, in an intention-to-treat analysis as we wanted this intervention to present a 
real-life quality improvement initiative. 
 
4.2 DISSEMINATION 
 
4.2.1 Dissemination to other centres 
 
With opioid use in surgery being topically relevant, there was interest in other institutions and 
surgical specialties in the experience with the STOP Narcotics protocol. As there is limited 
external validity in our academic, single-centre design we a decided to implement the STOP 
Narcotics initiative in outpatient general surgical procedures in the community hospitals of St. 
Thomas, Ontario and Stratford, Ontario. St. Thomas Elgin General Hospital (five full-time 
general surgeons) and Stratford General Hospital (six full-time general surgeons) are two 
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regional community hospitals in southwestern Ontario and both perform high volumes of 
outpatient general surgery procedures.  
 
These hospitals perform outpatient laparoscopic cholecystectomy, open ventral hernia repair, 
open inguinal hernia repair, breast surgery and anorectal surgery and similar multipronged 
protocols and instruction sheets were created specific to their institution and with their hospital 
practices in mind. In addition, these hospitals created a general “minor surgery” instruction sheet 
which was used for laparoscopic appendectomy patients, carpal tunnel surgery and other minor 
procedures they felt appropriate to be included.  
 
A formal educational meeting was held with each of the two groups of regional partners with all 
of the general surgeons in attendance. An anesthetist from our institution also held morning 
teaching rounds with their anesthetists to introduce the STOP Narcotics protocol. 
Implementation was assigned through a few of the surgeons taking on responsibilities at their 
centre. These surgeons looked after reviewing and distribution of the instruction sheets to ensure 
all surgeons were satisfied with the post-operative instructions, nursing education of the day 
surgery and PACU nurses and the office administrators and nurses, and providing education and 
obtaining support from the anesthesia department for the intervention.  
 
Both centres continued the intervention for 3 months at which time a review was held to assess 
progress. All surgeons were satisfied with the STOP Narcotics initiative, and subjectively did not 
notice any change in patient satisfaction or pain control. They did not subjectively notice an 
increase in phone calls or prescription refills. There had been no resistance, but actual 
encouragement from the anesthesia department to implement and continue with this initiative, 
and routinely dexamethasone, ketorolac and ondansetron were being given intra-operatively.  
 
One hospital had electronic prescriptions and the other pre-printed the standardized opioid-
rescue and meloxicam prescriptions. Both locations did not have difficulty integrating these into 
their regular practice. The electronic version was more user-friendly once the post-operative 
prescriptions and instructions had been placed in a package.  
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Although we attempted to gather surveys at each post-operative clinic visit from these 
community hospitals, feedback was unanimous from the surgeons that in a busy clinic, having 
patients fill out a post-operative pain survey was difficult and cumbersome to the flow of 
patients. Therefore, we did not reach statistical power in either of these groups so cannot reach 
conclusions about non-inferior pain control at either hospital.  
 
Other positive feedback included increased nursing satisfaction from the standardization of 
prescribing practices and post-operative instructions among the surgeons. It was felt this should 
be a division-wide initiative, with multiple surgeons championing the initiative rather than 
having a single surgeon lead the initiative as it can be difficult to correct a colleague’s practice.  
 
4.2.2 Dissemination to other surgical specialities 
 
At London Health Sciences Centre we are currently holding monthly meetings with the surgical 
specialties of orthopedics, obstetrics and gynecology, urology, otolaryngology, plastic surgery 
and pediatric anesthesia with both a staff member and resident representing each specialty. We 
have obtained buy-in for similar initiatives in each of these specialties. Currently, we are in the 
process of creating similar protocols and instruction sheets which are specific to each of these 
surgical specialities and procedures.  
 
4.2.3 Follow up and study dissemination 
 
The dissemination of this information first started with presentation of the hernia and 
laparoscopic cholecystectomy work completed prior to this thesis, at the American College of 
Surgeons Clinical Congress. This was then published in the Journal of the American College of 
Surgeons. Currently, the work on outpatient breast surgery and anorectal procedures will be 
presented at the American Society of Breast Surgeons Annual Meeting 2019 and the Annual 
Scientific Meeting of the American Society of Colon and Rectal Surgeons 2019. This work is 
also currently submitted to two scientific journals.  
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This work has been presented in the following meetings: Canadian Association of General 
Surgeons Resident Research Meeting, Health Quality Ontario Webinar, Ontario Surgical Quality 
Improvement Network, Choosing Wisely Canada Meeting, and the Ontario Association of 
General Surgeons Annual Meeting. The protocol has also been presented at the following 
hospitals: St. Thomas Elgin General Hospital, Stratford General Hospital, Brampton Civic 
Hospital, Hanover and District Hospital, Woodstock General Hospital, The Ottawa Hospital 
(both campuses), Chatham-Kent Health Alliance, Bluewater Health Hospital, Belleville General 
Hospital, Vancouver General Hospital (Vancouver, BC), Alberta Health Services (Edmonton, 
AB), and Foothills Medical Centre (Calgary, AB).  
 
This work was also disseminated through the following radio broadcasts and news releases: CTV 
news London (press release and upcoming interview); Canadian Press Article – Republished by 
CBC health, The National Post, Ottawa Citizen, Yahoo! News, CTV Toronto, City TV Toronto, 
Sudbury Star, Victoria Times, Colonist, Kingston Whig-Standard and 8 other smaller 
newspapers. Also published in the London Free Press, Sarnia Observer, and Stratford Beacon-
Herald. Radio station broadcasts included AM 980, 1290 CFPL, CBC London and Windsor, 
CMHL Hamilton, CHED Edmonton, 660 News Calgary, 96.3 Toronto, AM 740 Toronto. 
Specific hospital press included: Eurekalert Press Release: Hospital News and MedicalXpress.   
 
4.3 CONCLUSION 
 
In this quality improvement initiative, the STOP Narcotics was successfully implemented as a 
multidisciplinary, divisional, multipronged “patient pain care bundle” to institute multiple 
evidence-based interventions in outpatient breast and anorectal surgery. While every patient 
requires an individualized approach, our study has shown the value of a standardized bundle, to 
guide surgeons in ensuring a comprehensive pain control strategy with responsible opioid 
prescribing. We demonstrated that adequate pain control may be obtained, while significantly 
decreasing opioid prescribing, and often eliminating opioid utilization by patients, through 
dedicated health systems change by the entire care team. This decreases the opioid exposure risk 
in patients and reduces the amount of excess medication which is left for misuse or diversion. 
Considering the number of outpatient breast and anorectal procedures completed per year, if 
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there is continued implementation by other institutions and surgical disciplines this would have a 
significant impact on the amount of opioid prescribed and play a primary prevention role in the 
opioid crisis. This also may provide a framework for future analgesia guidelines in outpatient 
breast and anorectal surgery.  
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5.2 Appendix 5.2 Post-Operative Pain Management Strategy for Anorectal Surgery 
 
Patients were asked to notify their surgeon if they had a history of stomach ulcers, liver disease, 
kidney disease or allergies to any of these medications.  
 
First 3 days (72 hours) after surgery:  
1. Meloxicam 7.5 mg: 1 tablet PO, q12 hours, for 3 days (prescription). 
2. Acetaminophen 500 mg; 1-2 tablets PO q6hours, for 3 days. 
If the patient does not have coverage for Meloxicam, you may prescribe the following: 
1. Naproxen 200 mg (Aleve): Take 2 tablets orally, every 12 hours, for 3 days.  
To maximize pain relief, it was strongly recommended to take both of these medications. 
 
After 3 days (72 hours) after surgery: 
1. Continue Acetaminophen 500 mg: 1-2 tablets PO q6hours PRN.   
2. Ibuprofen 400 mg; 1 tablet PO q6hours PRN.   
 
Patients are given separate prescriptions with the following instructions:  
Tramadol 50 mg: 1 tab PO q6hours PRN (10 tabs) (Expiry date 7 days) 
If the patient does not have coverage for Tramadol, you may prescribe the following.  
Codeine 30 mg: 1 tab PO q6hours PRN (10 tabs) (Expiry date 7 days) 
Patients were given instructions to only fill this prescription, if the above measures do not 
adequately control their pain. 
 
Metronidazole 500 mg: 1 tab PO q12hours for 5 days.  
Polyethylene glycol (PEG) 17 g: Take once to twice daily to avoid constipation.  
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5.3 Appendix 5.3 Multi-pronged Opioid-sparing Intervention for Breast Surgery 
 
Patient Education:  
Patients were educated by staff, residents, and nurses through written instructions (standardized 
education sheets) and verbal reinforcement on two occasions: the initial surgical consultation and 
the day of surgery. Patients’ expectations surrounding the surgery, discomfort and the recovery 
process were clarified. Instructions focused on optimal use of non-opioid analgesic medications 
(acetaminophen and NSAIDs) and conservative measures such as ice therapy. Patients were 
instructed to only fill a separate, rescue 10-tablet opioid prescription, if their discomfort was not 
satisfactorily controlled by other measures. Finally, patients were educated on appropriate 
medication disposal. 
  
Provider Education:  
Surgeons, anesthetists, residents, post-anesthesia care unit (PACU) nurses, and pre-admission 
clinic (PAC) staff were educated through divisional rounds, meetings and emails. This education 
focused on current evidence surrounding opioid use and prescribing after surgery, and the 
development and commencement of the STOP Narcotics initiative.  
 
Intra-operative Protocol:  
During the surgical safety checklist, it was reinforced with the anesthetist that patients were to 
receive ketorolac (15-30 mg IV), ondansetron (4-8 mg IV), and dexamethasone (4-8 mg IV) 
during the surgery. All surgeons were encouraged to use local anesthetic field blocks. 
 
Post-operative Protocol:  
Patients received a prescription for an NSAID (meloxicam 7.5 mg or naproxen 400 mg) to be 
taken twice daily for 72 hours. Acetaminophen 500 mg was also to be taken every 6 hours for 72 
hours. After 72 hours patients were instructed to take ibuprofen 400 mg and acetaminophen 500 
mg as needed. A separate rescue prescription of 10-tablets of an opioid prescription was 
provided (Tramadol 50 mg or Codeine 30 mg). This prescription expired in 7 days, with 
instructions to only fill if discomfort was not sufficiently achieved through other analgesic and 
conservative measures. Ice therapy was also used at the discretion of the surgeon and patient.  
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5.4 Appendix 5.4 Post-operative Pain Management Instructions for Breast Surgery 
 
Patients were asked to notify their surgeon if they had a history of stomach ulcers, liver disease, 
kidney disease or allergies to any of these medications.  
 
Ice therapy was suggested as a conservative therapy to help reduce swelling and discomfort of 
the breast or axilla for the first day after surgery.  
 
First 3 days (72 hours) after surgery:  
1. Meloxicam 7.5 mg: 1 tablet PO, q12 hours, for 3 days (prescription). 
2. Acetaminophen 500 mg; 1-2 tablets PO q6hours, for 3 days. 
If the patient does not have coverage for Meloxicam, you may prescribe the following: 
1. Naproxen 200 mg (Aleve): Take 2 tablets orally, every 12 hours, for 3 days.  
To maximize pain relief, it was strongly recommended to take both of these medications. 
 
After 3 days (72 hours) after surgery: 
1. Continue Acetaminophen 500 mg: 1-2 tablets PO q6hours as needed.   
2. Ibuprofen 400 mg; 1 tablet PO q6hours, as needed.   
 
Patients are given separate prescriptions with the following instructions:  
Tramadol 50 mg: 1 tab PO q6hours PRN (10 tabs) (Expiry date 7 days) 
 
If the patient does not have coverage for Tramadol, you may prescribe the following.  
Codeine 30 mg: 1 tab PO q6hours PRN (10 tabs) (Expiry date 7 days) 
 
Patients were given instructions to only fill this prescription, if the above measures do not 
adequately control their pain.  
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5.5 APPENDIX 5.5 THE STANDARDIZATION OF OUTPATIENT PROCEDURE 
NARCOTICS: A PROSPECTIVE NON-INFERIORITY STUDY TO REDUCE 
OPIOID USE IN OUTPATIENT GENERAL SURGICAL PROCEDURES.  
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